Skyward/2025/FY/Annual report: Difference between revisions
Content deleted Content added
Index sections (topic tags) |
Index sections (topic tags) |
||
| (7 intermediate revisions by the same user not shown) | |||
Line 16:
''This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K.''
{{Indexing|Cover|
<div style="overflow-x:auto">
Line 217:
</div>
{{Indexing|Audit Information|
<div style="overflow-x:auto">
Line 243:
== Business ==
{{Indexing|Who We Are|Skyward Specialty,
* Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company <sup>p. 1</sup>.
Line 264:
* All insurance company subsidiaries are group rated and have financial strength ratings of "A" (Excellent) from A.M. Best Company, with a stable outlook <sup>p. 1</sup>.
{{Indexing|Apollo Acquisition|
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers") <sup>p. 2</sup>.
Line 280:
* David Ibeson will continue as CEO of Apollo, leading Apollo's growth as a subsidiary of Skyward Specialty, along with Apollo’s management team <sup>p. 2</sup>.
{{Indexing|Our Business and Our Strategy|
* The company operates with one reportable segment, offering a broad range of insurance coverages across various market niches <sup>p. 3</sup>.
Line 332:
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 3</sup>.
{{Indexing|Our Competitive Strengths|
* The company focuses on profitable niches in the market that require technical underwriting and claims management, which act as barriers to entry <sup>p. 4</sup>.
Line 374:
* Executive leadership has additional long-term incentive targets directly tied to growth in book value per share <sup>p. 4</sup>.
{{Indexing|Our Strategy in Action|
* The company's "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability within its niches and create superior long-term shareholder value through growth in book value per share <sup>p. 5</sup>.
Line 404:
* Loss reserves represent the company's best estimate of ultimate losses <sup>p. 5</sup>.
{{Indexing|Marketing and Distribution|
* The company's marketing and distribution approach mirrors its underwriting strategy and is central to its "Rule Our Niche" strategy <sup>p. 6</sup>.
Line 414:
* This distribution approach enables effective and efficient access to targeted business based on market niche needs and dynamics <sup>p. 6</sup>.
{{Indexing|Underwriting|
* The company's underwriting approach is central to its "Rule Our Niche" strategy and market success <sup>p. 7</sup>.
Line 436:
* Underwriting controls and procedures are regularly reviewed to ensure underwriters profitably underwrite in each market served <sup>p. 7</sup>.
{{Indexing|Claims Management|
* Skyward's claims department operates under six guiding principles: prompt and comprehensive investigations using advanced analytics and technology; quality claims handling and customer engagement; timely establishment of reserves based on best estimates; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management for superior legal defense and cost monitoring <sup>p. 8</sup>.
Line 454:
* Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues, educating underwriters on loss experience for risk selection <sup>p. 8</sup>.
{{Indexing|Technology|Skyward Specialty Insurance Group, SkyBI, predictive analytics technology, AI, core transactional platforms, policy administration, underwriting workbench, billing, claims systems, accident & health, global property, agriculture, credit (re)insurance, surety|2264mja9fc|kind=prose|order=11|f1=Technology platform|v1=SkyBI|f2=Technology type|v2=Predictive analytics technology, AI|f3=Core transactional platforms|v3=Policy administration, underwriting workbench, billing, claims systems}}
* Technology is central to Skyward Specialty Insurance Group's operations and decision-making, aiming for long-term competitive advantages <sup>p. 9</sup>.
Line 485:
* The company constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools <sup>p. 9</sup>.
{{Indexing|Reinsurance|
* The company strategically purchases reinsurance from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility <sup>p. 10</sup>.
Line 509:
* The ''allowance for uncollectible reinsurance'' was $2.3 million at December 31, 2025, and 2024 <sup>p. 10</sup>.
{{Indexing|Maximum company retention by line of business
<div style="overflow-x:auto">
Line 552:
(3) Catastrophe loss protection is purchased up to $36.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event.
{{Indexing|Reinsurance
<div style="overflow-x:auto">
Line 604:
| class="col-m" style="text-align:right" | A
|-
| style="text-align:left" | '''Top 10 Total'''
| class="col-m" style="text-align:right" | '''661,130'''
| class="col-m" style="text-align:right" | —
|-
Line 612:
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left
| class="col-m" style="text-align:right
| class="col-m" style="text-align:right
|}
</div>
Line 620:
(1) This reinsurer facilitates our eMaxx captive. At December 31, 2025, we held collateral in a statutory trust of $235.2 million on our net reinsurance recoverables.
{{Indexing|Enterprise Risk Management|
* ''ERM'' is embedded in nearly every aspect of the company and guides day-to-day activities <sup>p. 11</sup>.
Line 647:
* ''ERM'' is a central component of the strategy to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment <sup>p. 11</sup>.
{{Indexing|Reserves|Reserves,
* Reserves are maintained for specific claims incurred and reported, IBNR reserves, and uncollectible reinsurance <sup>p. 12</sup>.
Line 664:
* Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” <sup>p. 12</sup>.
{{Indexing|Investments|
* The company aims to maintain a balanced investment portfolio primarily consisting of investments that provide predictable and stable returns <sup>p. 13</sup>.
Line 679:
* For further discussion on investments, including market risks, refer to Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments" <sup>p. 13</sup>.
{{Indexing|Competition|
* The specialty lines property & casualty insurance market comprises numerous markets and sub-markets <sup>p. 14</sup>.
Line 688:
* Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, and AXIS Capital Holdings, Ltd. <sup>p. 14</sup>.
{{Indexing|Our Structure|
* Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC) <sup>p. 15</sup>.
Line 712:
* ''Imperium Insurance Company'' has a direct relationship with Oklahoma Specialty Insurance Company (Oklahoma insurance corporation) <sup>p. 15</sup>.
{{Indexing|Direct
<div style="overflow-x:auto">
Line 752:
| style="text-align:right" | 39.9
|-
| style="text-align:left
| style="text-align:right
|}
</div>
Line 759:
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g1.jpg|thumb|Our Structure]]
{{Indexing|Ratings|Skyward Specialty Insurance Group, Inc.
* ''Skyward Specialty Insurance Group, Inc.'' has an "A" (Excellent) rating with a stable outlook from A.M. Best <sup>p. 16</sup>.
Line 769:
* ''Ratings'' are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company <sup>p. 16</sup>.
{{Indexing|Regulation|
* The company is regulated by insurance regulatory authorities in the states where it conducts business <sup>p. 17</sup>.
Line 794:
* Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction <sup>p. 17</sup>.
{{Indexing|Intellectual Property|
* The company has applied for various ''trademark registrations'' in the United States at both federal and state levels <sup>p. 18</sup>.
Line 800:
* The company monitors its ''trademarks and service marks'' and protects them from unauthorized use as necessary <sup>p. 18</sup>.
{{Indexing|Employees and Human Capital|
* As of ''December 31, 2025'', the company had approximately ''611 employees'' <sup>p. 19</sup>.
Line 819:
* Such events could lead to a decline in the common stock price, potentially resulting in a loss of part or all of an investment <sup>p. 20</sup>.
{{Indexing|Summary of Material Risk Factors|
* ''Financial condition and results of operations'' could be materially adversely affected by inaccurate assessment of underwriting risk <sup>p. 21</sup>.
Line 839:
* ''Integration of Apollo'' may present unforeseen challenges, including difficulties with technology systems, business processes, and risk management frameworks, potentially causing operational disruptions, increased costs, or delays in realizing anticipated strategic benefits <sup>p. 21</sup>.
{{Indexing|Risks Related to Our Business and Industry|
* The company's financial condition and results of operations could be materially adversely affected if it does not accurately assess its underwriting risk <sup>p. 22</sup>.
*
* Employee decisions, including management and underwriters, in the ordinary course of business involve exposing the company to risk <sup>p. 22</sup>.
* Competition in the insurance industry is intense, coming from other specialty insurance companies, standard insurance companies, and underwriting agencies <sup>p. 22</sup>.
* Competition factors include price, reputation, perceived financial strength, distribution partner relationships, product terms, independent rating agency ratings, claims payment speed, and the experience of the underwriting team <sup>p. 22</sup>.
* Increasing consolidation in the insurance industry may further intensify competition <sup>p. 22</sup>.
* New industry or legislative developments could also increase competition <sup>p. 22</sup>.
* Inability to compete successfully could change supply and demand for insurance, affect pricing at risk-adequate rates, impact retention of existing business, or hinder underwriting new business on favorable terms, adversely affecting operating results <sup>p. 22</sup>.
* The business relies on insurance retail agents, brokers, wholesalers, and program administrators, exposing it to risks from these distribution channels <sup>p. 22</sup>.
* Substantially all products are distributed through independent retail agents and brokers who own "renewal rights," making the business model dependent on these relationships <sup>p. 22</sup>.
* The company is also dependent on relationships wholesalers and program administrators maintain with agents and brokers <sup>p. 22</sup>.
* Relationships with retail agents, brokers, wholesalers, and program administrators can be discontinued at any time or become unprofitable <sup>p. 22</sup>.
*
* Premiums collected by brokers from policyholders, in certain jurisdictions, may be considered paid to the company even if not remitted, exposing the company to credit risk <sup>p. 22</sup>.
* Failure by brokers to remit premiums has not been material to date, but the company may be required to provide coverage despite unpaid premiums <sup>p. 22</sup>.
* Limitations on the ability to cancel policies for non-payment could reduce underwriting profits and adversely affect financial condition and results <sup>p. 22</sup>.
* The company reviews the financial condition of potential new brokers and periodically reviews existing distributors against profitability standards and business objectives <sup>p. 22</sup>.
*
* Deterioration in distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers <sup>p. 22</sup>.
* Distributors exceeding granted authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability <sup>p. 22</sup>.
* Continued or increased consolidation of insurance distribution firms could materially affect sales channels, potentially leading to loss of market access or share <sup>p. 22</sup>.
* Loss of talent knowledgeable about products or increased commission costs due to larger distributors gaining negotiating leverage could negatively impact the company <sup>p. 22</sup>.
* Accelerated digitization exposes the company to risks related to distributors' ability to keep pace, as customers may prefer technology-driven distributors <sup>p. 22</sup>.
* Inability to purchase third-party reinsurance in desired amounts or on acceptable terms could materially adversely affect the business <sup>p. 22</sup>.
* Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility <sup>p. 22</sup>.
* Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure, potentially requiring a reduction in underwriting commitments <sup>p. 22</sup>.
*
*
*
* The reserving process reviews historical data and considers factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends <sup>p. 22</sup>.
* Variables affecting loss exposure are influenced by internal and external events, and loss reserves are continually monitored using new information and statistical techniques <sup>p. 22</sup>.
* The process assumes past experience, adjusted for current developments and trends, predicts future events, but actual results may deviate substantially from estimates <sup>p. 22</sup>.
* Uncertainties impacting reserve adequacy include:
** Time required to fully appreciate covered loss extent, leading to increased loss estimates over time <sup>p. 22</sup>.
** Retroactive enforcement of new theories of liability by courts, potentially expanding coverage <sup>p. 22</sup>.
** Volatility in financial markets, economic events, and external factors increasing claim frequency/severity, and elevated inflation increasing loss costs <sup>p. 22</sup>.
** Adverse economic factors (recession, high unemployment) potentially reducing policy sales or increasing claim frequency/severity and premium defaults <sup>p. 22</sup>.
** Increased "social inflation" costs (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse) increasing claim frequency/severity and affecting reserve adequacy <sup>p. 22</sup>.
** Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves <sup>p. 22</sup>.
** Entering new lines of business or new theories of claims may lead to unanticipated increases in claim frequency and handling costs <sup>p. 22</sup>.
* Inadequate reserves would require an increase in reserves, reducing net income and stockholders’ equity in the period the deficiency is identified <sup>p. 22</sup>.
* Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating <sup>p. 22</sup>.
*
*
* A.M. Best's ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile <sup>p. 22</sup>.
* A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation) <sup>p. 22</sup>.
* As of the filing date, A.M. Best assigned the company a financial strength rating of "A" (Excellent) with a stable outlook <sup>p. 22</sup>.
* A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations and are not an evaluation for investors or a recommendation to buy/sell securities <sup>p. 22</sup>.
* A.M. Best'
* A.M. Best periodically reviews and may revise ratings downward based on balance sheet strength, operating performance, and business profile <sup>p. 22</sup>.
* Factors that could affect A.M. Best's analysis and potentially lead to a downgrade include:
** Changes in business practices from the organizational plan that no longer support the rating <sup>p. 22</sup>.
**
** Losses exceeding loss reserves <sup>p. 22</sup>.
** Unresolved issues with government regulators <sup>p. 22</sup>.
** Inability to retain senior management or other key personnel <sup>p. 22</sup>.
**
**
* A downgrade or withdrawal of the rating could cause distribution partners and insureds to choose higher-rated competitors, increase reinsurance costs or reduce availability, or severely limit/prevent writing new and renewal insurance contracts <sup>p. 22</sup>.
* Rating organizations may heighten scrutiny, increase review frequency/scope, request additional information, or increase capital requirements for certain rating levels <sup>p. 22</sup>.
*
*
* There is no assurance that loss limitations or exclusions in policies will be enforceable as intended <sup>p. 22</sup>.
*
* Policy limitations on claim periods, potentially shorter than statutory periods, may be nullified by courts or regulators, or legislation could modify/bar their use <sup>p. 22</sup>.
* Governmental actions could result in higher than anticipated losses and LAE, materially adversely affecting financial condition or results <sup>p. 22</sup>.
* Court decisions, such as the 1995 Montrose decision in California, could narrowly read policy exclusions, expanding coverage and requiring new exclusions <sup>p. 22</sup>.
* These issues may broaden coverage beyond underwriting intent or increase claim frequency/severity, with full liability potentially not known for years after contract issuance <sup>p. 22</sup>.
*
* Reinsurance contracts require premium payments to carriers who reimburse for covered claims, often many years later <sup>p. 22</sup>.
*
* The current reinsurance program aims to limit financial risk, but reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies <sup>p. 22</sup>.
* Disputes with reinsurers could be time-consuming, costly, and uncertain of success, leading to increased net losses <sup>p. 22</sup>.
* As of December 31, 2025, the company had ''reinsurance recoverables'' of $1,119.9 million <sup>p. 22</sup>.
*
* Factors affecting claim payment accuracy and timeliness include claims representative training/experience (including TPAs), management effectiveness, and appropriate procedures/systems <sup>p. 22</sup>.
* Failure to pay claims accurately and timely could lead to regulatory/administrative actions, litigation, and reputational damage <sup>p. 22</sup>.
* Ineffective TPA management or internal staff/TPA inability to handle claim volume could adversely affect workload capacity <sup>p. 22</sup>.
* Decreased quality of claims work could adversely affect operating margins and potentially require slowing growth in affected markets <sup>p. 22</sup>.
* Severe weather conditions, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results, and financial condition <sup>p. 22</sup>.
* Catastrophes include natural events (severe winter weather, convective storms/tornadoes, windstorms, earthquakes, hailstorms, thunderstorms, fires) and man-made events (explosions, war, terrorist attacks, riots) <sup>p. 22</sup>.
* Changing weather patterns and climatic conditions (e.g., global warming) have increased unpredictability and frequency of natural disasters, including in new areas and operating markets <sup>p. 22</sup>.
* Climate change may increase the frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks <sup>p. 22</sup>.
* A natural disaster or catastrophe loss could materially adversely affect business, financial condition, and results <sup>p. 22</sup>.
* Catastrophes can impact the company even without direct insurance coverage, such as the 2025 California wildfires, as affected policyholders may cancel other policies <sup>p. 22</sup>.
* Increased frequency and severity of weather events, including hurricanes or convective storms (difficult to model), could materially adversely affect the ability to predict, quantify, reinsure, and manage catastrophe risk, increasing losses <sup>p. 22</sup>.
* Losses from catastrophes depend on the frequency and severity of insured events and total insured exposure in affected areas <sup>p. 22</sup>.
* The incidence and severity of catastrophes and severe weather are inherently unpredictable <sup>p. 22</sup>.
* Exposure to losses is managed by analyzing probability and severity of loss events and their impact on underwriting and investment portfolios <sup>p. 22</sup>.
* Indirect impacts can occur if insured businesses are affected by catastrophes not directly covered, leading to inability or unwillingness to pay premiums on other products <sup>p. 22</sup>.
* Inability to obtain reinsurance coverage at reasonable rates and adequate amounts for severe weather and catastrophes could materially adversely affect business and results <sup>p. 22</sup>.
* The business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events <sup>p. 22</sup>.
* While policy terms are expected to preclude coverage for virus-related claims, court decisions and governmental actions may challenge exclusions or interpretations <sup>p. 22</sup>.
* Changes in domestic and international climate policy programs/initiatives, and related legislation/regulation, are unpredictable but could materially adversely affect business, operational, and financial results <sup>p. 22</sup>.
* Program administrators are provided with specific quoting and binding authority, and their failure to comply with guidelines could adversely affect results <sup>p. 22</sup>.
* The company markets and distributes certain insurance products through program administrators with limited quoting and binding authority, who then sell to insureds via retail agents and brokers <sup>p. 22</sup>.
* Program administrators can bind certain risks without initial approval <sup>p. 22</sup>.
* Non-compliance by program administrators with underwriting guidelines could bind the company to unanticipated risks, adversely affecting results <sup>p. 22</sup>.
* If actual renewals of existing contracts or new business from repeat insureds do not meet expectations, written premium and future results could be materially adversely affected <sup>p. 22</sup>.
* Most contracts are for a one-year term and are renewable; some insureds are repeat customers with new contracts <sup>p. 22</sup>.
* Financial forecasting includes assumptions about renewal rates and repeat business <sup>p. 22</sup>.
* The insurance and reinsurance industries are cyclical with intense price-based competition <sup>p. 22</sup>.
* Failure of actual renewals/repeat business to meet expectations, or choosing not to write renewals/accept repeat business due to pricing, would materially adversely affect future written premium and operations <sup>p. 22</sup>.
* Increased public attention to environmental, social, and governance (ESG) matters may lead to negative public perception, reputational harm, additional costs, or impact stock price <sup>p. 22</sup>.
* Failure, or perceived failure, to meet investor/customer ESG expectations could harm business and reputation <sup>p. 22</sup>.
* Backlash from investors or customers regarding ESG topics could also harm business and reputation <sup>p. 22</sup>.
* Damage to reputation from providing policies to certain insureds could decrease demand for products, materially adversely affect business/results, and require resources to rebuild reputation/brand <sup>p. 22</sup>.
* Changes in accounting practices and future pronouncements may materially affect reported financial results <sup>p. 22</sup>.
* Developments in accounting practices may require considerable additional expenses for compliance, especially if retroactive application or comparative information for prior periods is needed <sup>p. 22</sup>.
* The impact of accounting changes and future pronouncements on net income, shareholder's equity, and other financial statement items is unpredictable <sup>p. 22</sup>.
* Insurance subsidiaries must comply with statutory accounting principles (SAP) <sup>p. 22</sup>.
* SAP and its components are constantly reviewed by the NAIC, its task forces/committees, and state insurance departments to address emerging issues and improve financial reporting <sup>p. 22</sup>.
* Various proposals before NAIC committees/task forces, if enacted, could negatively affect insurance industry participants <sup>p. 22</sup>.
* The NAIC continuously examines existing laws and regulations, and the impact of reforms is unpredictable <sup>p. 22</sup>.
* The use of derivatives to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral/margin call liquidity pressures, and valuation uncertainty <sup>p. 22</sup>.
* These risks could adversely affect financial condition and results of operations <sup>p. 22</sup>.
* Risks include hedge ineffectiveness due to imperfect correlation, basis risk where futures prices don't align with cash market prices, and liquidity pressures from margin calls/collateral requirements during adverse market movements <sup>p. 22</sup>.
* Reliance on market-based models introduces valuation uncertainty, potentially causing hedges to perform differently than expected <sup>p. 22</sup>.
* These factors may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results <sup>p. 22</sup>.
{{Indexing|Risks Related to the Market and Economic Conditions|Adverse economic factors,
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can reduce policy sales, increase claim frequency, lead to premium defaults, or cause claim falsification, impacting growth and profitability <sup>p. 23</sup>.
Line 967 ⟶ 1,011:
* Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities <sup>p. 23</sup>.
{{Indexing|Risks Related to the Regulatory Environment|
*
*
*
*
* Significant changes in laws and regulations could limit discretion or increase business costs <sup>p. 24</sup>.
* State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues <sup>p. 24</sup>.
* Our insurance subsidiaries are part of an "insurance holding company system" in Texas, requiring notice to the Texas Department of Insurance for certain affiliate transactions <sup>p. 24</sup>.
* Prior notification requirements may cause business delays and additional expenses <sup>p. 24</sup>.
* Failure to file required notifications or comply with Texas insurance regulations could lead to significant fines, penalties, and impaired working relationships with the Texas Department of Insurance <sup>p. 24</sup>.
* State insurance regulators have broad discretion to deny or revoke licenses for regulatory violations <sup>p. 24</sup>.
* Our practices, based on interpretations of regulations or industry norms, may differ from regulatory authorities' interpretations <sup>p. 24</sup>.
* Lack of requisite licenses/approvals or non-compliance could lead to temporary suspension or preclusion from activities in a state, or other penalties <sup>p. 24</sup>.
* Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs <sup>p. 24</sup>.
*
* These requirements establish minimum risk-based capital to support
* Falling below
* Failure to maintain required risk-based capital levels could adversely affect
*
*
* The U.S. federal government
* Changes to U.S. tax laws and new tax policies could negatively impact the overall economy and
* Legislative or other
*
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences <sup>p. 24</sup>.
* On July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States <sup>p. 24</sup>.
* The OBBBA modifies
* Based on current analysis,
* Regulations and
*
* As of December 31, 2025, we had gross federal income tax NOLs of approximately $40.3 million available to offset future taxable income, prior to Section 382 limitations <sup>p. 24</sup>.
* These NOLs are set to expire beginning in 2032 <sup>p. 24</sup>.
* Under Section 382 of the Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income <sup>p. 24</sup>.
* Future ownership changes,
*
* As a holding company with substantially all operations conducted by insurance subsidiaries, our liquidity and ability to pay dividends and service debt depend on obtaining cash dividends or other permitted payments from our insurance subsidiaries <sup>p. 24</sup>.
* The continued operation and growth of our business will require substantial capital <sup>p. 24</sup>.
*
*
* State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to declare stockholder dividends <sup>p. 24</sup>.
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 24</sup>.
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits <sup>p. 24</sup>.
* State insurance regulators have broad powers to prevent statutory surplus reduction to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted <sup>p. 24</sup>.
* State insurance regulators may adopt more restrictive statutory provisions regarding dividend payments by our insurance subsidiaries in the future <sup>p. 24</sup>.
*
* Investors may need to sell common stock after price appreciation, which may not occur,
* Investors seeking immediate cash dividends should not purchase our common stock <sup>p. 24</sup>.
* Applicable insurance laws may make a change of control difficult <sup>p. 24</sup>.
* Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner <sup>p. 24</sup>.
* Approval depends on factors
* Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer <sup>p. 24</sup>.
* Acquiring 10% or more of
* These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control of Skyward Specialty, even if desirable to
{{Indexing|Risks Related to Our Liquidity and Access to Capital|Future capital requirements
* ''Future capital requirements'' depend on factors such as the ability to write new business successfully and establish adequate premium rates and reserves to cover losses <sup>p. 25</sup>.
Line 1,038 ⟶ 1,079:
* The ''current credit market environment'' and macro-economic challenges may adversely impact the ability to borrow sufficient funds or sell assets/equity to repay existing debt <sup>p. 25</sup>.
{{Indexing|Risks Related to Our Operations|
* Loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company <sup>p. 26</sup>.
Line 1,122 ⟶ 1,163:
* Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention <sup>p. 26</sup>.
{{Indexing|Risks Related to Ownership of Our Common Stock|
* The company expects to incur increased costs as a public company and its management devotes substantial time to compliance initiatives <sup>p. 27</sup>.
Line 1,232 ⟶ 1,273:
* The number of holders of record does not represent the total number of stockholders due to shares being held by brokers and other institutions on behalf of stockholders <sup>p. 31</sup>.
{{Indexing|Securities Authorized for Issuance Under Equity Compensation Plans|
* Information regarding equity compensation plans will be included in the definitive proxy statement filed with the SEC for the 2026 Annual Meeting of Stockholders ("2026 Proxy Statement") <sup>p. 32</sup>.
Line 1,238 ⟶ 1,279:
* Part III of the document contains information on securities authorized for issuance under equity compensation plans <sup>p. 32</sup>.
{{Indexing|Recent Sales of Unregistered Equity Securities|Unregistered securities,
* ''Unregistered securities'' information is provided for the period covered by this Annual Report on Form 10-K <sup>p. 33</sup>.
Line 1,245 ⟶ 1,286:
* The payment also included the issuance of ''3,679,332 unregistered shares'' of the Company’s common stock <sup>p. 33</sup>.
{{Indexing|Performance Graph|
*
* The comparison period
*
* The
* The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act <sup>p. 34</sup>.
* The graph is not subject to liabilities under Section 18 of the Exchange Act <sup>p. 34</sup>.
* The graph is not deemed to be incorporated by reference into any of the company's filings under the Securities Act <sup>p. 34</sup>.
* ''Skyward Specialty Insurance Group, Inc.
** January 13, 2023: $100.00 <sup>p. 34</sup>
** December 31, 2023: Approximately $175.00 <sup>p. 34</sup>
** December 31, 2024: Approximately $265.00 <sup>p. 34</sup>
** December 31, 2025: Approximately $268.00 <sup>p. 34</sup>
* ''Nasdaq Composite Index
** January 13, 2023: $100.00 <sup>p. 34</sup>
** December 31, 2023: Approximately $138.00 <sup>p. 34</sup>
** December 31, 2024: Approximately $173.00 <sup>p. 34</sup>
** December 31, 2025: Approximately $210.00 <sup>p. 34</sup>
* ''Nasdaq Insurance Index
** January 13, 2023: $100.00 <sup>p. 34</sup>
** December 31, 2023: Approximately $105.00 <sup>p. 34</sup>
** December 31, 2024: Approximately $128.00 <sup>p. 34</sup>
** December 31, 2025: Approximately $
{{Indexing|Stock performance of Skyward Specialty Insurance Group, Inc.
<div style="overflow-x:auto">
Line 1,305 ⟶ 1,345:
== Management’s Discussion and Analysis of Financial Condition and Results of Operations ==
{{Indexing|Overview|Specialty insurance provider
* The company is a specialty insurance provider of commercial P&C products and solutions, primarily in the United States, on both non-admitted (E&S) and admitted bases <sup>p. 35</sup>.
Line 1,336 ⟶ 1,376:
* As of ''December 31, 2025'', the company recognized ''$14.0 million'' in transaction expenses related to the acquisition <sup>p. 35</sup>.
{{Indexing|Results of Operations|Net income, net income attributable to common stockholders, basic
* ''Net income'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>.
Line 1,360 ⟶ 1,400:
* ''Combined ratio'' was 90.0% for the year ended December 31, 2025, compared to 90.0% for the year ended December 31, 2024 <sup>p. 36</sup>.
{{Indexing|
<div style="overflow-x:auto">
Line 1,369 ⟶ 1,409:
|-
! style="text-align:left" | ($ in thousands)
! class="col-
! class="col-
|-
| style="text-align:left" | Gross written premiums
Line 1,380 ⟶ 1,420:
| style="text-align:right" | -619,654
|-
| style="text-align:left" | '''Net written premiums'''
| style="text-align:right" | '''1,406,232'''
| style="text-align:right" | '''1,123,578'''
|-
| style="text-align:left" | '''Net earned premiums'''
| style="text-align:right" | '''1,304,505'''
| style="text-align:right" | '''1,056,722'''
|-
| style="text-align:left" | Commission and fee income
Line 1,400 ⟶ 1,440:
| style="text-align:right" | 311,757
|-
| class="wt-indent-1" style="text-align:left" | '''Underwriting income (1)'''
| style="text-align:right" | '''138,979'''
| style="text-align:right" | '''81,859'''
|-
| style="text-align:left" | Net investment income
Line 1,432 ⟶ 1,472:
| style="text-align:right" | 28.9%
|-
| style="text-align:left" | '''Combined ratio'''
| style="text-align:right" | '''89.3%'''
| style="text-align:right" | '''92.3%'''
|-
| style="text-align:left" | Adjusted loss and LAE ratio (1)
Line 1,444 ⟶ 1,484:
| style="text-align:right" | 28.9%
|-
| style="text-align:left" | '''Adjusted combined ratio (1)'''
| style="text-align:right" | '''NM (2)'''
| style="text-align:right" | '''91.2%'''
|-
| style="text-align:left" | Return on equity
Line 1,469 ⟶ 1,509:
(2) Not meaningful.
{{Indexing|Reconciliation of Non-GAAP Financial Measures|
* The provided text indicates that tables are available for reconciliation of ''adjusted operating income'' to net income for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>.
Line 1,479 ⟶ 1,519:
* The provided text indicates that tables are available for reconciliation of ''adjusted return on tangible equity'' to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>.
{{Indexing|Reconciliation of adjusted operating income
<div style="overflow-x:auto">
Line 1,536 ⟶ 1,576:
| style="text-align:right" | -3,470
|-
| style="text-align:left" | '''Adjusted operating income'''
| style="text-align:right" | '''213,043'''
| style="text-align:right" | '''167,372'''
| style="text-align:right" | '''162,554'''
| style="text-align:right" | '''126,582'''
|}
</div>
{{Indexing|Reconciliation of
<div style="overflow-x:auto">
Line 1,592 ⟶ 1,632:
| style="text-align:right" | -167
|-
| style="text-align:left" | '''Underwriting income'''
| style="text-align:right" | '''138,979'''
| style="text-align:right" | '''81,859'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 1,614 ⟶ 1,654:
| style="text-align:right" | -11,598
|-
| style="text-align:left" | '''Adjusted losses and LAE'''
| style="text-align:right" | '''658,211'''
|-
| style="text-align:left" | Loss ratio
Line 1,623 ⟶ 1,663:
| style="text-align:right" | 1.1%
|-
| style="text-align:left" | '''Adjusted loss ratio'''
| style="text-align:right" | '''62.3%'''
|-
| style="text-align:left" | Combined ratio
Line 1,632 ⟶ 1,672:
| style="text-align:right" | 1.1%
|-
| style="text-align:left" | '''Adjusted combined ratio'''
| style="text-align:right" | '''91.2%'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 1,653 ⟶ 1,693:
| style="text-align:right" | 87,348
|-
| style="text-align:left" | '''Tangible stockholders’ equity'''
| style="text-align:right" | '''921,525'''
| style="text-align:right" | '''706,651'''
|}
</div>
{{Indexing|Adjusted return on equity
<div style="overflow-x:auto">
Line 1,671 ⟶ 1,711:
| style="text-align:right" | 126,582
|-
| style="text-align:left" | '''Denominator: average stockholders’ equity'''
| style="text-align:right" | '''901,782'''
| style="text-align:right" | '''727,515'''
|-
| style="text-align:left" | Adjusted return on equity
Line 1,681 ⟶ 1,721:
</div>
{{Indexing|Return on tangible equity
<div style="overflow-x:auto">
Line 1,693 ⟶ 1,733:
| style="text-align:right" | 118,828
|-
| style="text-align:left" | '''Denominator: average tangible stockholders’ equity'''
| style="text-align:right" | '''814,088'''
| style="text-align:right" | '''639,624'''
|-
| style="text-align:left" | Return on tangible equity
Line 1,703 ⟶ 1,743:
</div>
{{Indexing|Adjusted return on tangible equity
<div style="overflow-x:auto">
Line 1,715 ⟶ 1,755:
| style="text-align:right" | 126,582
|-
| style="text-align:left" | '''Denominator: average tangible stockholders’ equity'''
| style="text-align:right" | '''814,088'''
| style="text-align:right" | '''639,624'''
|-
| style="text-align:left" | Adjusted return on tangible equity
Line 1,725 ⟶ 1,765:
</div>
{{Indexing|Underwriting Results|Gross written premiums
* ''Gross written premiums'' increased by USD 423.1m YoY compared to 2024 <sup>p. 38</sup>.
Line 1,757 ⟶ 1,797:
* The decrease in income from ''equities'' was due to the sale of the equity portfolio in Q3 2025 <sup>p. 38</sup>.
{{Indexing|Gross written premiums by line of business
<div style="overflow-x:auto">
Line 1,821 ⟶ 1,861:
| style="text-align:right" | 4.3%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
Line 1,831 ⟶ 1,871:
(1) Excludes exited business.
{{Indexing|Losses and LAE by type
<div style="overflow-x:auto">
Line 1,851 ⟶ 1,891:
! class="col-s" style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE
| style="text-align:right" | 786,949
| style="text-align:right" | 60.3%
Line 1,857 ⟶ 1,897:
| style="text-align:right" | 60.6%
|-
| class="wt-indent-1" style="text-align:left" | Cat loss and LAE (1)
| style="text-align:right" | 15,548
| style="text-align:right" | 1.2%
Line 1,869 ⟶ 1,909:
| style="text-align:right" | 1.1%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
Line 1,879 ⟶ 1,919:
(1) Current accident year.
{{Indexing|Loss and LAE reserve development|Loss and LAE reserve development, Accident Year, Reserve development on losses subject to LPT|rhstabgyn2|do9an7x5kp|kind=table|order=50}}
<div style="overflow-x:auto">
Line 1,913 ⟶ 1,953:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Reserve development on losses subject to LPT'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''25,300'''
|-
| style="text-align:left" | '''Reserve development on losses excluding losses subject to LPT'''
| style="text-align:right" |
| style="text-align:right" | '''428'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 1,953 ⟶ 1,993:
| style="text-align:right" | 15.3%
|-
| style="text-align:left" | '''Underwriting, acquisition and insurance expenses'''
| style="text-align:right" | '''377,359'''
| style="text-align:right" | '''28.9%'''
| style="text-align:right" | '''311,757'''
| style="text-align:right" | '''29.5%'''
|-
| style="text-align:left" | Less: commission and fee income
Line 1,965 ⟶ 2,005:
| style="text-align:right" | (0.6%)
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Net investment income and gains
<div style="overflow-x:auto">
Line 1,997 ⟶ 2,037:
| style="text-align:right" | 2,581
|-
| style="text-align:left" | '''Net investment income'''
| style="text-align:right" | '''83,619'''
| style="text-align:right" | '''80,600'''
|-
| style="text-align:left" | '''Net unrealized (losses) gains on securities still held'''
| style="text-align:right" |
| style="text-align:right" | '''7,921'''
|-
| style="text-align:left" | Net realized gains (losses)
Line 2,009 ⟶ 2,049:
| style="text-align:right" | -1,579
|-
| style="text-align:left" | '''Net investment gains'''
| style="text-align:right" | '''22,149'''
| style="text-align:right" | '''6,342'''
|}
</div>
{{Indexing|Investments|Fixed income
* ''Fixed income portfolio'' primarily consists of investment grade fixed income securities, predominantly highly-rated and liquid bonds, and commercial mortgage loans <sup>p. 39</sup>.
Line 2,052 ⟶ 2,092:
* ''Equity portfolio sale'': Almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>.
{{Indexing|Investment portfolio by asset class
<div style="overflow-x:auto">
Line 2,096 ⟶ 2,136:
| style="text-align:right" | 8.6%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Fixed income portfolio by security type
<div style="overflow-x:auto">
Line 2,154 ⟶ 2,194:
| style="text-align:right" | 22.2%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Commercial mortgage loans'''
| style="text-align:right" | '''9,902'''
| style="text-align:right" | '''0.5%'''
| style="text-align:right" | '''26,490'''
| style="text-align:right" | '''2.0%'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Fixed income portfolio by credit rating
<div style="overflow-x:auto">
Line 2,218 ⟶ 2,258:
| style="text-align:right" | 1.7%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Equities portfolio by type
<div style="overflow-x:auto">
Line 2,258 ⟶ 2,298:
| style="text-align:right" | 1.1%
|-
| style="text-align:left" | '''Equities'''
| style="text-align:right" | '''1,174'''
| style="text-align:right" | '''100.0%'''
| style="text-align:right" | '''106,254'''
| style="text-align:right" | '''100.0%'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 2,312 ⟶ 2,352:
</div>
{{Indexing|Other Items|
* ''Income tax expense'' for the year ended December 31, 2025, was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024 <sup>p. 40</sup>.
Line 2,318 ⟶ 2,358:
* For a reconciliation between actual federal income tax expense and the amount computed at the statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, “Income Taxes” in the consolidated financial statements included in Item 8 of this Form 10-K <sup>p. 40</sup>.
{{Indexing|Liquidity and Capital Resources|Holding
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries GMIC, HSIC, IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma) <sup>p. 41</sup>.
Line 2,338 ⟶ 2,378:
* Management believes there is sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months <sup>p. 41</sup>.
{{Indexing|Cash Flows|
* The most significant source of cash is from premiums received from insureds, typically at the beginning of the coverage period, net of related commission <sup>p. 42</sup>.
Line 2,354 ⟶ 2,394:
* ''Net cash used in investing activities'' in 2024 was driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments <sup>p. 42</sup>.
{{Indexing|Cash flows
<div style="overflow-x:auto">
Line 2,378 ⟶ 2,418:
| style="text-align:right" | -4,232
|-
| style="text-align:left" | '''Change in cash and cash equivalents and restricted cash'''
| style="text-align:right" | '''41,589'''
| style="text-align:right" | '''57,189'''
|}
</div>
{{Indexing|Credit Agreements|Credit Agreements, FHLB Loan
* ''FHLB Loan'' was entered into on August 30, 2024, with the Federal Home Loan Bank of Dallas (FHLB) <sup>p. 43</sup>.
Line 2,436 ⟶ 2,476:
* ''Deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 43</sup>.
{{Indexing|Share Repurchase Program|
* In ''October 2024'', the Board of Directors approved a share repurchase program. <sup>p. 44</sup>
Line 2,445 ⟶ 2,485:
* As of ''December 31, 2025'', no shares had been repurchased under this plan. <sup>p. 44</sup>
{{Indexing|Contractual Obligations and Commitments|
* ''Reserves for losses and LAE'' represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses <sup>p. 45</sup>.
Line 2,458 ⟶ 2,498:
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled $857.9 million at December 31, 2024 <sup>p. 45</sup>.
{{Indexing|Reinsurance balances recoverable
<div style="overflow-x:auto">
Line 2,485 ⟶ 2,525:
| style="text-align:right" | 80,242
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Critical Accounting Policies|Critical Accounting Policies, Critical accounting estimates
* Critical accounting estimates are those important to portraying financial condition and results of operations and require significant judgment <sup>p. 46</sup>.
Line 2,523 ⟶ 2,563:
* In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division <sup>p. 46</sup>.
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves <sup>p. 46</sup>.
*
* Reserve estimates reflect current inflation in legal claims’ settlements <sup>p. 46</sup>.
* Reserve estimates assume no subjection to losses from significant new legal liability theories <sup>p. 46</sup>.
* Reserve estimates assume no significant changes in the regulatory and legislative environment <sup>p. 46</sup>.
* The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific, significant new regulation or legislation <sup>p. 46</sup>.
* In the event of significant new regulation or legislation, the company will attempt to quantify its impact, but accuracy or success is not assured <sup>p. 46</sup>.
* The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE <sup>p. 46</sup>.
Line 2,541 ⟶ 2,581:
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known, with adjustments included in current operations <sup>p. 46</sup>.
* ''Development'' is the amount by which estimated losses differ from those originally reported for a period <sup>p. 46</sup>.
* Development is ''
* Development is ''
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period
* A ''5% change in net IBNR'' would result in a ''$51.8 million change'' in reserves for losses and LAE <sup>p. 46</sup>.
* A ''5% change in net IBNR'' would result in a ''$40.9 million change'' in net income and stockholders’ equity <sup>p. 46</sup>.
{{Indexing|Impact of a 5% change in net IBNR on reserves, income, and equity
<div style="overflow-x:auto">
Line 2,585 ⟶ 2,625:
| style="text-align:right" | 69.2%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Recent Accounting Pronouncements|Recent Accounting Pronouncements, ASU 2023-09,
* In December 2023, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)" <sup>p. 47</sup>.
Line 2,618 ⟶ 2,658:
== Financial Statements ==
{{Indexing|Report of Independent Registered Public Accounting Firm|
* ''Opinion'': The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles <sup>p. 49</sup>.
Line 2,631 ⟶ 2,671:
* ''Date'': February 28, 2024 <sup>p. 49</sup>.
{{Indexing|Opinion on Internal Control Over Financial Reporting|
* ''Internal control over financial reporting'' of Skyward Specialty Insurance Group, Inc. and subsidiaries was audited as of December 31, 2025 <sup>p. 50</sup>.
Line 2,639 ⟶ 2,679:
* The ''report dated March 2, 2026'' expressed an unqualified opinion on the consolidated financial statements and related notes and schedules <sup>p. 50</sup>.
{{Indexing|Basis for Opinion|
* The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting <sup>p. 51</sup>.
Line 2,649 ⟶ 2,689:
* The auditor believes their audit provides a reasonable basis for their opinion <sup>p. 51</sup>.
{{Indexing|Definition and Limitations of Internal Control Over Financial Reporting|Internal control over financial reporting,
* ''Internal control over financial reporting'' is a process designed to provide reasonable assurance about the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles <sup>p. 52</sup>.
Line 2,658 ⟶ 2,698:
* ''Projections of effectiveness evaluations'' to future periods carry the risk that controls may become inadequate due to changing conditions or that compliance with policies/procedures may deteriorate <sup>p. 52</sup>.
Caption: Report of independent registered public accounting firm
| /s/ Ernst & Young LLP |
Line 2,665 ⟶ 2,705:
| March 2, 2026 |
{{Indexing|Report of Independent Registered Public Accounting Firm|
* ''Opinion'': The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America <sup>p. 53</sup>.
Line 2,682 ⟶ 2,722:
* ''Report Date'': February 29, 2024 <sup>p. 53</sup>.
{{Indexing|Opinion on the Financial Statements|
* The consolidated financial statements of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, and for the three years ended December 31, 2025, have been audited <sup>p. 54</sup>.
Line 2,691 ⟶ 2,731:
* The report dated March 2, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting <sup>p. 54</sup>.
{{Indexing|Basis for Opinion|
* The Company's management is responsible for the financial statements <sup>p. 55</sup>.
Line 2,703 ⟶ 2,743:
* The auditors believe their audits provide a reasonable basis for their opinion <sup>p. 55</sup>.
{{Indexing|Critical Audit Matter|
* The critical audit matter discussed arises from the current period audit of the financial statements <sup>p. 56</sup>.
Line 2,712 ⟶ 2,752:
* Communicating the critical audit matter does not provide a separate opinion on the matter or its related account/disclosure <sup>p. 56</sup>.
{{Indexing|Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses|
* ''Company’s reserves'' for unpaid losses and loss adjustment expenses (LAE) were USD 2.3bn at December 31, 2025 <sup>p. 57</sup>.
Line 2,729 ⟶ 2,769:
* We also reviewed the ''development of prior year reserve estimates'' <sup>p. 57</sup>.
Caption: Report of independent registered public accounting firm
| /s/ Ernst & Young LLP |
Line 2,737 ⟶ 2,777:
| March 2, 2026 |
{{Indexing|Consolidated balance sheets|
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 58</sup>.
{{Indexing|Consolidated balance sheets
<div style="overflow-x:auto">
Line 2,764 ⟶ 2,804:
! class="col-s" style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively)
| style="text-align:right" | 1,856,303
| style="text-align:right" | 1,292,218
|-
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $ 468 and $ 243 , respectively)
| style="text-align:right" | 32,822
| style="text-align:right" | 39,153
Line 2,792 ⟶ 2,832:
| style="text-align:right" | 274,929
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Cash and cash equivalents
Line 2,832 ⟶ 2,872:
| style="text-align:right" | 86,698
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Liabilities and stockholders’ equity'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 2,872 ⟶ 2,912:
| style="text-align:right" | 19,536
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Stockholders’ equity'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left" | Common stock, $ 0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively
| style="text-align:right" | 405
| style="text-align:right" | 401
Line 2,896 ⟶ 2,936:
| style="text-align:right" | 97,120
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Consolidated statements of operations and comprehensive income|
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 59</sup>.
{{Indexing|Consolidated statements of
<div style="overflow-x:auto">
Line 2,924 ⟶ 2,964:
|-
! style="text-align:left" | Revenues:
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Net earned premiums
Line 2,953 ⟶ 2,993:
| style="text-align:right" | ( 632 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Losses and loss adjustment expenses
Line 2,988 ⟶ 3,028:
| style="text-align:right" | 5,364
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Income before income taxes'''
| style="text-align:right" | '''216,424'''
| style="text-align:right" | '''152,739'''
| style="text-align:right" | '''110,102'''
|-
| style="text-align:left" | Income tax expense
Line 3,003 ⟶ 3,043:
| style="text-align:right" | 24,118
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | '''170,028'''
| style="text-align:right" | '''118,828'''
| style="text-align:right" | '''85,984'''
|-
| style="text-align:left" | '''Net income attributable to participating securities'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''1,677'''
|-
| style="text-align:left" | '''Net income attributable to common stockholders'''
| style="text-align:right" | '''170,028'''
| style="text-align:right" | '''118,828'''
| style="text-align:right" | '''84,307'''
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | '''170,028'''
| style="text-align:right" | '''118,828'''
| style="text-align:right" | '''85,984'''
|-
| style="text-align:left" | '''Other comprehensive income:'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Unrealized gains and losses on investments:
Line 3,038 ⟶ 3,083:
| style="text-align:right" | ( 4,984 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Comprehensive income'''
| style="text-align:right" | '''203,605'''
| style="text-align:right" | '''119,661'''
| style="text-align:right" | '''106,516'''
|-
| style="text-align:left" | '''Per share data:'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Basic earnings per share
Line 3,053 ⟶ 3,103:
| style="text-align:right" | 2.34
|-
| style="text-align:left" | '''Diluted earnings per share'''
| style="text-align:right" | '''4.07'''
| style="text-align:right" | '''2.87'''
| style="text-align:right" | '''2.24'''
|-
| style="text-align:left" | '''Weighted-average common shares outstanding'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,068 ⟶ 3,118:
| style="text-align:right" | 36,031,907
|-
| style="text-align:left" | '''Diluted'''
| style="text-align:right" | '''41,808,046'''
| style="text-align:right" | '''41,377,460'''
| style="text-align:right" | '''38,317,534'''
|}
</div>
{{Indexing|Consolidated statements of stockholders’ equity|
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 60</sup>.
{{Indexing|Consolidated statements of
<div style="overflow-x:auto">
Line 3,092 ⟶ 3,142:
|-
! style="text-align:left" | Preferred shares:
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Balance at beginning of year
Line 3,106 ⟶ 3,156:
| style="text-align:right" | ( 1,969,660 )
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
|-
| style="text-align:left" | Balance at beginning of year
Line 3,126 ⟶ 3,176:
| style="text-align:right" | 16,305,113
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''40,511,222'''
| style="text-align:right" | '''40,127,908'''
| style="text-align:right" | '''39,863,756'''
|-
| style="text-align:left" | Balance at beginning of year
Line 3,136 ⟶ 3,186:
| style="text-align:right" | 20
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
|-
| style="text-align:left" | '''Common stock:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,161 ⟶ 3,211:
| style="text-align:right" | 48
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''405'''
| style="text-align:right" | '''401'''
| style="text-align:right" | '''399'''
|-
| style="text-align:left" | '''Treasury stock:'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Balance at beginning of year
Line 3,171 ⟶ 3,226:
| style="text-align:right" | ( 2 )
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
|-
| style="text-align:left" | '''Additional paid-in capital:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,196 ⟶ 3,251:
| style="text-align:right" | 124,496
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''730,555'''
| style="text-align:right" | '''718,598'''
| style="text-align:right" | '''710,855'''
|-
| style="text-align:left" | '''Stock notes receivable:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,216 ⟶ 3,271:
| style="text-align:right" | 1,349
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''( 5,562 )'''
|-
| style="text-align:left" | '''Accumulated other comprehensive income (loss):'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,236 ⟶ 3,291:
| style="text-align:right" | 20,532
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''11,457'''
| style="text-align:right" | '''( 22,120 )'''
| style="text-align:right" | '''( 22,953 )'''
|-
| style="text-align:left" | '''Retained earnings (accumulated deficit):'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,261 ⟶ 3,316:
| style="text-align:right" | 85,984
|-
| style="text-align:left" | '''Balance at December 31'''
| style="text-align:right" | '''267,148'''
| style="text-align:right" | '''97,120'''
| style="text-align:right" | '''( 21,708 )'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Consolidated statements of cash flows|
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 61</sup>.
{{Indexing|Consolidated statements of cash flows||cs6p6hop55|kind=table|order=86}}
<div style="overflow-x:auto">
Line 3,290 ⟶ 3,345:
|-
! style="text-align:left" | Cash flows from operating activities:
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Net income
Line 3,389 ⟶ 3,444:
| style="text-align:right" | ( 5,047 )
|-
| style="text-align:left" | '''Net cash provided by operating activities'''
| style="text-align:right" | '''408,076'''
| style="text-align:right" | '''305,115'''
| style="text-align:right" | '''338,187'''
|-
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale
Line 3,469 ⟶ 3,524:
| style="text-align:right" | 11,913
|-
| style="text-align:left" | '''Net cash used in investment activities'''
| style="text-align:right" | '''( 366,898 )'''
| style="text-align:right" | '''( 243,694 )'''
| style="text-align:right" | '''( 493,809 )'''
|-
| style="text-align:left" | Employee share purchases
Line 3,499 ⟶ 3,554:
| style="text-align:right" | 129,597
|-
| style="text-align:left" | '''Net cash provided by (used in) financing activities'''
| style="text-align:right" | '''411'''
| style="text-align:right" | '''( 4,232 )'''
| style="text-align:right" | '''130,947'''
|-
| style="text-align:left" | '''Net increase (decrease) in cash and cash equivalents and restricted cash'''
| style="text-align:right" | '''41,589'''
| style="text-align:right" | '''57,189'''
| style="text-align:right" | '''( 24,675 )'''
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1)
Line 3,514 ⟶ 3,569:
| style="text-align:right" | 125,011
|-
| style="text-align:left" | '''Cash and cash equivalents and restricted cash at end of period (1)'''
| style="text-align:right" | '''199,114'''
| style="text-align:right" | '''157,525'''
| style="text-align:right" | '''100,336'''
|-
| style="text-align:left" | '''Supplemental disclosure of cash flow information:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 3,533 ⟶ 3,588:
(1) The sum of cash and cash equivalents and restricted cash from the Consolidated Balance Sheets.
{{Indexing|A. Description of Business|Skyward Specialty Insurance Group, Inc.,
* ''Skyward Specialty Insurance Group, Inc.'' (the "Company") is a Delaware corporation organized in 2006, operating as an insurance holding company <sup>p. 62</sup>.
* The Company operates
* The Company has four wholly owned U.S.-based insurance company subsidiaries
** ''Great Midwest Insurance Company'' ("GMIC")
** ''Houston Specialty Insurance Company'' ("HSIC")
** ''Imperium Insurance Company'' ("IIC")
** ''Oklahoma Specialty Insurance Company'' ("OSIC")
* The Company has a wholly owned captive reinsurance company subsidiary, ''Skyward Re'', domiciled in the Cayman Islands <sup>p. 62</sup>.
** Skyward Re assumed net reserves for certain divisions
* The Company has three non-risk bearing wholly owned subsidiaries <sup>p. 62</sup>.
** ''Skyward Underwriters Agency, Inc.'' ("SUA")
** ''Skyward Service Company'' provides various administrative services to the
** ''Skyward Specialty No. 1 Limited'' is a
* On January 1, 2026, the Company completed the acquisition of ''Apollo Group Holdings Limited'' for an aggregate consideration of approximately $555.0 million <sup>p. 62</sup>.
** Additional information
{{Indexing|B. Basis of Presentation|
* The Company's consolidated financial statements are prepared according to Generally Accepted Accounting Principles in the United States of America (GAAP) <sup>p. 63</sup>.
Line 3,561 ⟶ 3,615:
* The Company's actual results may vary from these estimates <sup>p. 63</sup>.
{{Indexing|C. Consolidation|
* The Company consolidates an entity if it meets the definition of a variable interest entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through a majority of voting interest or other arrangements <sup>p. 64</sup>.
Line 3,576 ⟶ 3,630:
* Further details and required disclosures regarding this VIE are provided in Note 7 <sup>p. 64</sup>.
{{Indexing|D. Cash and Cash Equivalents|Cash and cash equivalents
* ''Cash and cash equivalents'' include cash on hand and fixed maturity securities with original maturities of three months or less <sup>p. 65</sup>.
* The carrying value of the Company’s cash and cash equivalents approximates fair value <sup>p. 65</sup>.
{{Indexing|E. Restricted Cash|Restricted cash,
* ''Restricted cash'' is cash with a legal restriction on withdrawal or use by the consolidated group <sup>p. 66</sup>.
Line 3,590 ⟶ 3,644:
* ''Cash held'' in a depository account for others, or restricted by a state, is recorded as restricted cash <sup>p. 66</sup>.
{{Indexing|F. Investments|Available
* ''Available for Sale fixed maturities'' are carried at fair value <sup>p. 67</sup>.
Line 3,635 ⟶ 3,689:
* ''Net investment gains and losses'' are recognized in net income based upon the specific identification method <sup>p. 67</sup>.
{{Indexing|G. Derivatives|
* The Company uses ''commodity derivatives'' to assume risk and manage exposures in the insurance industry <sup>p. 68</sup>.
Line 3,649 ⟶ 3,703:
* Further details and required disclosures regarding derivatives can be found in ''Note 8'' <sup>p. 68</sup>.
{{Indexing|H. Reinsurance|
* The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis <sup>p. 69</sup>.
Line 3,690 ⟶ 3,744:
* ''Everest Reinsurance Co.'s'' financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024 <sup>p. 69</sup>.
{{Indexing|I. Concentration of Credit Risk|
* ''Financial instruments'' that could lead to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, excluding reinsurance recoverables <sup>p. 70</sup>.
Line 3,700 ⟶ 3,754:
* ''Failure by distribution sources'' to remit premiums could lead to premium write-offs and a corresponding loss of income <sup>p. 70</sup>.
{{Indexing|J. Deferred Policy Acquisition Costs|Policy acquisition costs,
* ''Policy acquisition costs'' include commissions and premium taxes that are directly related to new or renewal business production <sup>p. 71</sup>.
Line 3,711 ⟶ 3,765:
* Management determined that no premium deficiency existed as of December 31, 2025, and 2024 <sup>p. 71</sup>.
{{Indexing|K. Goodwill and Intangible Assets|Goodwill
* ''Goodwill and intangible assets'' are recorded following a business combination <sup>p. 72</sup>.
Line 3,721 ⟶ 3,775:
* The Company had ''no goodwill impairment'' for the years ended December 31, 2025, and 2024 <sup>p. 72</sup>.
{{Indexing|L. Property and Equipment|Property and equipment,
* ''Property and equipment'' is included in other assets on the Consolidated Balance Sheets <sup>p. 73</sup>.
Line 3,728 ⟶ 3,782:
* Depreciation periods range from three to seven years <sup>p. 73</sup>.
{{Indexing|M. Reserves for Losses and Loss Adjustment Expenses|Reserves for unpaid losses
* ''Reserves for unpaid losses and loss adjustment expenses (LAE)'' represent the Company's estimated ultimate cost
* The Company estimates reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 74</sup>.
*
* The Company regularly reviews and adjusts its estimates as experience develops or new information becomes known <sup>p. 74</sup>.
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 74</sup>.
* The ultimate liability may exceed or be less than the revised estimates, and the ultimate settlement of losses and related LAE may vary significantly from the estimate in the financial statements <sup>p. 74</sup>.
Line 3,739 ⟶ 3,793:
* If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves <sup>p. 74</sup>.
{{Indexing|N. Premiums|Property and casualty
* The Company recognizes property and casualty and surety premiums on a pro-rata basis over the policy terms <sup>p. 75</sup>.
Line 3,754 ⟶ 3,808:
* ''Unearned premiums'' (direct and ceded) are calculated on a pro-rata basis over the terms of the policies <sup>p. 75</sup>.
{{Indexing|O. Commission and Fee Income|SUA commission revenue,
* ''SUA commission revenue'' is generated from placing insurance policies on reinsurance programs via a reinsurance broker <sup>p. 76</sup>.
Line 3,767 ⟶ 3,821:
* Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur <sup>p. 76</sup>.
{{Indexing|P. Income Taxes|Income tax expense,
* ''Income tax expense'' is accrued for the tax effects of transactions reported on the consolidated financial statements <sup>p. 77</sup>.
Line 3,781 ⟶ 3,835:
* ''Premium tax expense'' is recognized within underwriting, acquisition, and insurance expense on the Consolidated Statements of Operations <sup>p. 77</sup>.
{{Indexing|Q. Fair Value of Financial Instruments|Fair value
* Fair value for each class of financial instrument is estimated based on the framework established in fair value accounting guidance <sup>p. 78</sup>.
Line 3,792 ⟶ 3,846:
* Further details regarding fair value disclosures are in Note 4 <sup>p. 78</sup>.
{{Indexing|R. Stock-Based Compensation|
* The estimated fair value of employee stock options and similar awards is expensed <sup>p. 79</sup>.
Line 3,802 ⟶ 3,856:
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period <sup>p. 79</sup>.
{{Indexing|S. Earnings Per Share|Basic earnings per share
* ''Basic earnings per share'' is calculated using the two-class method <sup>p. 80</sup>.
Line 3,818 ⟶ 3,872:
* When ''common share adjustments'' increase earnings per share or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents <sup>p. 80</sup>.
{{Indexing|T. Recent Accounting Pronouncements|ASU 2023-09,
* ''ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740)'' was issued by FASB in December 2023 <sup>p. 81</sup>.
Line 3,834 ⟶ 3,888:
* The Company is evaluating the effect of these amendments on its consolidated financial statements <sup>p. 81</sup>.
{{Indexing|2. Goodwill and Intangible Assets|
* The Company's indefinite-lived intangible assets include ''insurance licenses'' and ''trademarks'' <sup>p. 82</sup>.
Line 3,842 ⟶ 3,896:
* ''Amortization expense'' was approximately $1.5m for the year ended December 31, 2023 <sup>p. 82</sup>.
{{Indexing|Goodwill by segment at December 31, 2025
<div style="overflow-x:auto">
Line 3,874 ⟶ 3,928:
| style="text-align:right" | ( 46,707 )
|-
| style="text-align:left" | '''Net balance at December 31, 2025'''
| style="text-align:right" | '''46,756'''
| style="text-align:right" | '''6,781'''
| style="text-align:right" | '''10,204'''
| style="text-align:right" | '''1,993'''
| style="text-align:right" | '''65,734'''
|}
</div>
{{Indexing|Goodwill by segment at December 31, 2024
<div style="overflow-x:auto">
Line 3,915 ⟶ 3,969:
| style="text-align:right" | ( 46,707 )
|-
| style="text-align:left" | '''Net balance at December 31, 2024'''
| style="text-align:right" | '''46,756'''
| style="text-align:right" | '''6,781'''
| style="text-align:right" | '''10,204'''
| style="text-align:right" | '''1,993'''
| style="text-align:right" | '''65,734'''
|}
</div>
{{Indexing|Other intangible assets at December 31, 2025
<div style="overflow-x:auto">
Line 3,970 ⟶ 4,024:
| style="text-align:right" | ( 1,308 )
|-
| style="text-align:left" | '''Net balance at December 31, 2025'''
| style="text-align:right" | '''7,288'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''999'''
| style="text-align:right" | '''14,019'''
| style="text-align:right" | '''22,306'''
|}
</div>
{{Indexing|Other intangible assets at December 31, 2024
<div style="overflow-x:auto">
Line 4,018 ⟶ 4,072:
| style="text-align:right" | ( 1,087 )
|-
| style="text-align:left" | '''Net balance at December 31, 2024'''
| style="text-align:right" | '''6,596'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''999'''
| style="text-align:right" | '''14,019'''
| style="text-align:right" | '''21,614'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 4,054 ⟶ 4,108:
</div>
{{Indexing|3. Investments|Fixed maturity securities, held-to-maturity,
* ''Fixed maturity securities, held-to-maturity'' at December 31, 2025, consisted entirely of asset-backed securities not due at a single maturity date <sup>p. 83</sup>.
Line 4,078 ⟶ 4,132:
* At December 31, 2024, ''cash and investment securities on deposit'' had carrying values of approximately $66.8 million <sup>p. 83</sup>.
{{Indexing|Fixed maturity securities at December 31, 2025
<div style="overflow-x:auto">
Line 4,145 ⟶ 4,199:
| style="text-align:right" | 513,695
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 4,159 ⟶ 4,213:
| style="text-align:right" | 33,603
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Fixed maturity securities at December 31, 2024
<div style="overflow-x:auto">
Line 4,235 ⟶ 4,289:
| style="text-align:right" | 292,191
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 4,249 ⟶ 4,303:
| style="text-align:right" | 38,717
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Maturity distribution of fixed maturity securities
<div style="overflow-x:auto">
Line 4,290 ⟶ 4,344:
| style="text-align:right" | 513,695
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Fixed maturity securities
<div style="overflow-x:auto">
Line 4,377 ⟶ 4,431:
| style="text-align:right" | ( 1,353 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 4,393 ⟶ 4,447:
| style="text-align:right" | ( 48 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Fixed maturity securities
<div style="overflow-x:auto">
Line 4,492 ⟶ 4,546:
| style="text-align:right" | ( 1,834 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 4,508 ⟶ 4,562:
| style="text-align:right" | ( 436 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Allowance for credit losses on fixed maturity securities at December 31, 2025
<div style="overflow-x:auto">
Line 4,546 ⟶ 4,600:
| style="text-align:right" | ( 32 )
|-
| style="text-align:left" | '''Balance at December 31, 2025'''
| style="text-align:right" | '''7,000'''
| style="text-align:right" | '''468'''
|}
</div>
{{Indexing|Allowance for credit losses on fixed maturity securities at December 31, 2024
<div style="overflow-x:auto">
Line 4,568 ⟶ 4,622:
| style="text-align:right" | ( 104 )
|-
| style="text-align:left" | '''Balance at December 31, 2024'''
| style="text-align:right" | '''243'''
|}
</div>
{{Indexing|Net realized investment gains and losses
<div style="overflow-x:auto">
Line 4,602 ⟶ 4,656:
| style="text-align:right" | 2
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale
Line 4,622 ⟶ 4,676:
| style="text-align:right" | ( 20 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Equity securities
Line 4,642 ⟶ 4,696:
| style="text-align:right" | —
|-
| class="wt-indent-1" style="text-align:left" | '''Net investment gains'''
| style="text-align:right" | '''22,149'''
| style="text-align:right" | '''6,342'''
| style="text-align:right" | '''11,054'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 4,670 ⟶ 4,724:
</div>
{{Indexing|Net investment income by
<div style="overflow-x:auto">
Line 4,724 ⟶ 4,778:
| style="text-align:right" | 318
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Investment expenses
Line 4,734 ⟶ 4,788:
| style="text-align:right" | ( 5,557 )
|-
| style="text-align:left" | '''Net investment income'''
| style="text-align:right" | '''83,619'''
| style="text-align:right" | '''80,600'''
| style="text-align:right" | '''40,340'''
|}
</div>
{{Indexing|Components of
<div style="overflow-x:auto">
Line 4,760 ⟶ 4,814:
| style="text-align:right" | ( 5,420 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|4. Fair Value Measurements|Fair value measurements,
* The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value in consolidated financial statements <sup>p. 84</sup>.
* The ''market approach'' is generally
* ''Fair value of investments'' is primarily determined using data from third-party investment managers or pricing vendors <sup>p. 84</sup>.
* ''Periodic analyses'' are
*
** ''Level 1
** ''Level 2
** ''Level 3
* ''U.S. government securities, mutual funds, and common stock''
* ''Preferred stocks, municipal securities, corporate securities, and miscellaneous''
**
* ''Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities'' fair value is determined using a pricing model with market-based inputs like dealer quotes, market spreads, and yield curves <sup>p. 84</sup>.
** The model may evaluate individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs <sup>p. 84</sup>.
*
** The provider estimates value using the discount net present value of cash flows method with an unobservable discount rate <sup>p. 84</sup>.
** The discount rate spread reflects risk associated with future cash flows, including inflation, opportunity cost, and time value of money, representing Level 3 fair value inputs <sup>p. 84</sup>.
* ''Mortgage loans'' have variable interest rates and are collateralized by real property <sup>p. 84</sup>.
** Fair value
** The unobservable input
* ''Derivatives''
** Fair values
** This method represents Level 1 inputs <sup>p. 84</sup>.
* The Company
*
**
** These estimates may not be indicative of amounts realizable in a current market exchange, and different assumptions or methodologies could affect the estimated fair value <sup>p. 84</sup>.
* ''Fixed maturity securities, held-to-maturity'', consist of senior and junior notes with target rates of return <sup>p. 84</sup>.
** As of December 31, 2025,
* ''Investment in RedBird Capital Partners'' is included in other long-term investments
** The investment had a fair value of
** Procedures to assess
** The unfunded commitment related to the investment was
** The Company may sell its interest
**
** Net earned premiums related to this agreement were
* ''Notes payable'' carrying value approximates estimated fair value because they accrue interest at current market rates plus a spread <sup>p. 84</sup>.
** Fair value
* ''Subordinated debt'' consists of Unsecured Subordinated Notes, due May 24, 2039, with a fixed interest rate <sup>p. 84</sup>.
** Fair value
* Other financial instruments
{{Indexing|Fair value of
<div style="overflow-x:auto">
Line 4,829 ⟶ 4,886:
</div>
{{Indexing|Weighted average interest rates
<div style="overflow-x:auto">
Line 4,851 ⟶ 4,908:
</div>
{{Indexing|Fixed maturity securities
<div style="overflow-x:auto">
Line 4,905 ⟶ 4,962:
| style="text-align:right" | 513,695
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 4,917 ⟶ 4,974:
| style="text-align:right" | 33,603
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Preferred stocks
Line 4,929 ⟶ 4,986:
| style="text-align:right" | 1,174
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Mortgage loans'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''9,902'''
| style="text-align:right" | '''9,902'''
|-
| style="text-align:left" | '''Short-term investments'''
| style="text-align:right" | '''264,299'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''264,299'''
|-
| style="text-align:left" | '''Derivatives'''
| style="text-align:right" | '''34,857'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''34,857'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Fixed maturity securities
<div style="overflow-x:auto">
Line 5,015 ⟶ 5,072:
| style="text-align:right" | 292,191
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 5,027 ⟶ 5,084:
| style="text-align:right" | 38,717
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Common stocks
Line 5,051 ⟶ 5,108:
| style="text-align:right" | 40,839
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Mortgage loans'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''26,490'''
| style="text-align:right" | '''26,490'''
|-
| style="text-align:left" | '''Short-term investments'''
| style="text-align:right" | '''274,929'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''274,929'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 5,089 ⟶ 5,146:
| style="text-align:right" | 26,490
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Issuances
Line 5,113 ⟶ 5,170:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Balance at December 31, 2025'''
| style="text-align:right" | '''150,917'''
| style="text-align:right" | '''9,902'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 5,139 ⟶ 5,196:
| style="text-align:right" | 50,070
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Issuances
Line 5,159 ⟶ 5,216:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Balance at December 31, 2024'''
| style="text-align:right" | '''77,920'''
| style="text-align:right" | '''26,490'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Notes payable and subordinated debt
<div style="overflow-x:auto">
Line 5,211 ⟶ 5,268:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Notes payable'''
| style="text-align:right" | '''471,500'''
| style="text-align:right" | '''471,958'''
| style="text-align:right" | '''100,000'''
| style="text-align:right" | '''99,200'''
|-
| style="text-align:left" | Unsecured subordinated notes
Line 5,223 ⟶ 5,280:
| style="text-align:right" | 20,541
|-
| style="text-align:left" | '''Subordinated debt, net of debt issuance costs'''
| style="text-align:right" | '''19,569'''
| style="text-align:right" | '''21,020'''
| style="text-align:right" | '''19,536'''
| style="text-align:right" | '''20,541'''
|}
</div>
{{Indexing|5. Mortgage Loans|
* The Company invests in ''Separately Managed Accounts'' (SMA1 and SMA2) <sup>p. 85</sup>.
Line 5,245 ⟶ 5,302:
* As of December 31, 2025 and 2024, ''no mortgage loans were not producing income'' for the previous 12 months <sup>p. 85</sup>.
{{Indexing|Mortgage loans by property type
<div style="overflow-x:auto">
Line 5,266 ⟶ 5,323:
|-
| style="text-align:left" | —
| style="text-align:right" | '''9,902'''
| style="text-align:right" | '''26,490'''
|}
</div>
{{Indexing|Mortgage loans by property type
<div style="overflow-x:auto">
Line 5,306 ⟶ 5,363:
|-
| style="text-align:left" | —
| style="text-align:right" | '''1,622'''
| style="text-align:right" | '''5,155'''
| style="text-align:right" | '''5,474'''
|}
</div>
{{Indexing|6. Equity Method Investments and Other|Equity method investments
* The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities <sup>p. 86</sup>.
Line 5,320 ⟶ 5,377:
* As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2 <sup>p. 86</sup>.
{{Indexing|Indirect investments in collateralized loans and loan collateral
<div style="overflow-x:auto">
Line 5,377 ⟶ 5,434:
|-
| style="text-align:left" | —
| style="text-align:right" | '''53,498'''
| style="text-align:right" | —
| style="text-align:right" | '''65,325'''
| style="text-align:right" | —
|}
</div>
{{Indexing|Indirect investments in collateralized loans and loan collateral
<div style="overflow-x:auto">
Line 5,434 ⟶ 5,491:
|-
| style="text-align:left" | —
| style="text-align:right" | '''( 2,683 )'''
| style="text-align:right" | '''2,524'''
| style="text-align:right" | '''( 9,434 )'''
|}
</div>
{{Indexing|Indirect investments in collateralized loans and loan collateral
<div style="overflow-x:auto">
Line 5,465 ⟶ 5,522:
|-
| style="text-align:left" | —
| style="text-align:right" | '''22,094'''
| style="text-align:right" | '''29,260'''
|}
</div>
{{Indexing|Investment in RISCOM
<div style="overflow-x:auto">
Line 5,490 ⟶ 5,547:
| style="text-align:right" | 1,258
|-
| style="text-align:left" | '''Recorded investment balance'''
| style="text-align:right" | '''3,307'''
| style="text-align:right" | '''5,013'''
|}
</div>
{{Indexing|Investment in JVM Funds LLC
<div style="overflow-x:auto">
Line 5,516 ⟶ 5,573:
| style="text-align:right" | 605
|-
| style="text-align:left" | '''Recorded investment balance'''
| style="text-align:right" | '''14,911'''
| style="text-align:right" | '''17,229'''
|}
</div>
{{Indexing|Investment in indirect loans and loan collateral
<div style="overflow-x:auto">
Line 5,538 ⟶ 5,595:
| style="text-align:right" | 12,973
|-
| style="text-align:left" | '''Investment in indirect loans and loan collateral'''
| style="text-align:right" | '''23,867'''
| style="text-align:right" | '''33,269'''
|}
</div>
{{Indexing|7. Variable Interest Entity|
* Skyward consolidates ''Separate Account HSIC-01'' ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance <sup>p. 87</sup>.
Line 5,556 ⟶ 5,613:
* The presented assets only include ''third-party net assets'' and exclude intercompany balances, which were eliminated upon consolidation <sup>p. 87</sup>.
{{Indexing|Assets of HSIC-01
<div style="overflow-x:auto">
Line 5,572 ⟶ 5,629:
| style="text-align:right" | 34,856
|-
| style="text-align:left
| style="text-align:right
|}
</div>
{{Indexing|8 . Derivatives|
* The Company uses derivatives for financial risk management to mitigate price risk in insurance contracts exposed to commodity price fluctuations, specifically cattle and milk <sup>p. 88</sup>.
Line 5,590 ⟶ 5,647:
* For the year ended December 31, 2025, the Company recognized pre-tax net gains of USD 7.9m in losses and loss adjustment expenses <sup>p. 88</sup>.
{{Indexing|Derivative
<div style="overflow-x:auto">
Line 5,607 ⟶ 5,664:
</div>
{{Indexing|9. Allowance for Credit Losses|
* The Company analyzes the credit risk of its ''reinsurance recoverables'' by monitoring the financial strength rating of its reinsurers from A.M. Best <sup>p. 89</sup>.
Line 5,618 ⟶ 5,675:
* This $13.6 million increase was subsequently written-off <sup>p. 89</sup>.
{{Indexing|Premiums receivable
<div style="overflow-x:auto">
Line 5,642 ⟶ 5,699:
| style="text-align:right" | 498
|-
| style="text-align:left" | '''Balance at December 31, 2025'''
| style="text-align:right" | '''544,217'''
| style="text-align:right" | '''3,140'''
|}
</div>
{{Indexing|Premiums receivable
<div style="overflow-x:auto">
Line 5,672 ⟶ 5,729:
| style="text-align:right" | 128
|-
| style="text-align:left" | '''Balance at December 31, 2024'''
| style="text-align:right" | '''321,641'''
| style="text-align:right" | '''2,432'''
|}
</div>
{{Indexing|A.M. best ratings|A.M.
<div style="overflow-x:auto">
Line 5,707 ⟶ 5,764:
</div>
{{Indexing|Reinsurance recoverables
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | ($ in thousands)
! class="col-
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance
|-
Line 5,719 ⟶ 5,776:
| style="text-align:right" | 2,295
|-
| style="text-align:left" | '''Balance at December 31, 2025'''
| style="text-align:right" | '''1,119,880'''
| style="text-align:right" | '''2,295'''
|}
</div>
{{Indexing|Reinsurance recoverables
<div style="overflow-x:auto">
Line 5,745 ⟶ 5,802:
| style="text-align:right" | ( 13,585 )
|-
| style="text-align:left" | '''Balance at December 31, 2024'''
| style="text-align:right" | '''857,876'''
| style="text-align:right" | '''2,295'''
|}
</div>
{{Indexing|10. Property and Equipment|Depreciation expense
* ''Depreciation expense'' for property and equipment was USD 3.3m for the year ended December 31, 2025 <sup>p. 90</sup>.
Line 5,758 ⟶ 5,815:
* Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 90</sup>.
{{Indexing|
<div style="overflow-x:auto">
Line 5,786 ⟶ 5,843:
| style="text-align:right" | ( 29,355 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|11. Notes Payable & Subordinated Debt|
* On August 30, 2024, the Company entered into the ''FHLB Loan'' under the Advances and Security Agreement <sup>p. 91</sup>.
Line 5,843 ⟶ 5,900:
* These ''deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 91</sup>.
{{Indexing|12. Segment|
* The Company operates with one reportable segment, offering commercial property and casualty products and solutions primarily in the United States on both non-admitted (E&S) and admitted bases <sup>p. 92</sup>.
Line 5,856 ⟶ 5,913:
* This competitive analysis and the monitoring of budgeted versus actual results are used to assess segment performance and determine management's compensation <sup>p. 92</sup>.
{{Indexing|Segment information|Accident & Health, Agriculture and Credit (Re)insurance, Captives, Construction & Energy Solutions, Global Property, Professional Lines, Specialty Programs, Surety, Transactional E&S, Total continuing business, Exited business|1ut79wn2dy|kind=table|order=157}}
<div style="overflow-x:auto">
Line 5,910 ⟶ 5,967:
| style="text-align:right" | 128,236
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Exited business'''
| style="text-align:right" | '''( 81 )'''
| style="text-align:right" | '''( 17 )'''
| style="text-align:right" | '''( 18 )'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Underwriting income|Underwriting income,
<div style="overflow-x:auto">
Line 5,956 ⟶ 6,013:
| style="text-align:right" | 6,064
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Losses and LAE
Line 5,976 ⟶ 6,033:
| style="text-align:right" | 134,930
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Net underwriting income'''
| style="text-align:right" | '''138,979'''
| style="text-align:right" | '''81,859'''
| style="text-align:right" | '''76,526'''
|-
| style="text-align:left" | Reconciliation of net underwriting income to net income:
Line 5,991 ⟶ 6,048:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Net underwriting income'''
| style="text-align:right" | '''138,979'''
| style="text-align:right" | '''81,859'''
| style="text-align:right" | '''76,526'''
|-
| style="text-align:left" | '''Add:'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
Line 6,031 ⟶ 6,093:
| style="text-align:right" | 5,364
|-
| style="text-align:left" | '''Income before income taxes'''
| style="text-align:right" | '''216,424'''
| style="text-align:right" | '''152,739'''
| style="text-align:right" | '''110,102'''
|-
| style="text-align:left" | '''Income tax expense'''
| style="text-align:right" | '''46,396'''
| style="text-align:right" | '''33,911'''
| style="text-align:right" | '''24,118'''
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | '''170,028'''
| style="text-align:right" | '''118,828'''
| style="text-align:right" | '''85,984'''
|}
</div>
{{Indexing|Return on equity and book value per share
<div style="overflow-x:auto">
Line 6,069 ⟶ 6,131:
</div>
{{Indexing|13. Income Taxes|
* The Company paid ''federal income taxes'' of USD 37.0m in 2024 and USD 15.8m in 2023 <sup>p. 93</sup>.
Line 6,085 ⟶ 6,147:
* Management does not believe there are any ''uncertain tax benefits'' that could be recognized within the next twelve months that would impact the Company’s effective tax rate <sup>p. 93</sup>.
{{Indexing|Income tax expense from continuing operations
<div style="overflow-x:auto">
Line 6,101 ⟶ 6,163:
| style="text-align:right" | 7,661
|-
| class="wt-indent-1" style="text-align:left
| style="text-align:right
|-
| style="text-align:left" | Current tax expense
Line 6,122 ⟶ 6,184:
| style="text-align:right" | ( 885 )
|-
| style="text-align:left
| style="text-align:right
|}
</div>
{{Indexing|Income tax expense|Current
<div style="overflow-x:auto">
Line 6,143 ⟶ 6,205:
| style="text-align:right" | 9,382
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|U.S. federal statutory income tax rate reconciliation|U.S. federal statutory income tax rate, state income taxes, foreign tax effects, Bermuda statutory rate differential, effects of other cross-border tax laws, change of Valuation Allowance, nondeductible and nontaxable items, nondeductible transaction costs, other nondeductible and nontaxable items, effective tax rate|kmocop7wiu|kind=table|order=163}}
<div style="overflow-x:auto">
Line 6,196 ⟶ 6,258:
| style="text-align:right" | 0.3%
|-
| style="text-align:left" | '''Effective tax rate'''
| style="text-align:right" | '''46,396'''
| style="text-align:right" | '''21.4%'''
|}
</div>
Line 6,204 ⟶ 6,266:
(1) The following state(s) and/or local jurisdictions make up more than 50% of the state income taxes: Florida.
{{Indexing|Income tax expense at federal statutory rate
<div style="overflow-x:auto">
Line 6,236 ⟶ 6,298:
| style="text-align:right" | 1.2
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Total income taxes paid
<div style="overflow-x:auto">
Line 6,257 ⟶ 6,319:
| style="text-align:right" | 1,164
|-
| style="text-align:left
| style="text-align:right
|}
</div>
Line 6,264 ⟶ 6,326:
(1) No single state or jurisdiction accounts for greater than 5% of total taxes paid.
{{Indexing|Deferred tax assets|Deferred tax assets, net operating losses, losses and loss adjustment expenses, unearned premiums, unrealized losses on fixed maturity securities, available-for-sale, stock options/awards, other, total deferred tax assets before valuation allowance, valuation allowance, total deferred tax assets, deferred policy acquisition costs, other long-term investments, Section 481(a) adjustment, unrealized gains on equity securities|kmocop7wiu|kind=table|order=166}}
<div style="overflow-x:auto">
Line 6,300 ⟶ 6,362:
| style="text-align:right" | 6,067
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Valuation allowance
Line 6,308 ⟶ 6,370:
| style="text-align:right" | ( 586 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Deferred policy acquisition costs
Line 6,344 ⟶ 6,406:
| style="text-align:right" | 2,338
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Net deferred tax asset'''
| style="text-align:right" | '''27,865'''
| style="text-align:right" | '''30,486'''
|}
</div>
{{Indexing|Valuation allowance
<div style="overflow-x:auto">
Line 6,366 ⟶ 6,428:
| style="text-align:right" | 586
|-
| class="wt-indent-1" style="text-align:left" | Increase related to net operating loss
| style="text-align:right" | 68
| style="text-align:right" | —
|-
| style="text-align:left" | '''Balance at the end of the period'''
| style="text-align:right" | '''654'''
| style="text-align:right" | '''586'''
|}
</div>
{{Indexing|Tax Legislative Update|
* The One Big Beautiful Bill Act ("OBBB Act"), which includes a broad range of tax reform provisions, was signed into law in the United States on July 4, 2025 <sup>p. 94</sup>.
Line 6,382 ⟶ 6,444:
* No material impact from the OBBB Act is expected in 2026 <sup>p. 94</sup>.
{{Indexing|14. Reserves for Losses and Loss Adjustment Expenses|Net ultimate loss and LAE
* The Company evaluates net ultimate loss and LAE under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines <sup>p. 95</sup>.
Line 6,407 ⟶ 6,469:
** The favorable development in short-tail/monoline specialty lines was in the property line of business, primarily from accident years 2021 and 2022 <sup>p. 95</sup>.
{{Indexing|Reserves for losses and LAE, net of reinsurance
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | ($ in thousands)
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Reserves for losses and LAE, beginning of period
Line 6,426 ⟶ 6,488:
| style="text-align:right" | ( 435,986 )
|-
| style="text-align:left" | '''Reserves for losses and LAE, beginning of period, net of reinsurance'''
| style="text-align:right" | '''1,111,537'''
| style="text-align:right" | '''859,017'''
| style="text-align:right" | '''705,771'''
|-
| style="text-align:left" | '''Incurred, net of reinsurance, related to:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 6,446 ⟶ 6,508:
| style="text-align:right" | 10,770
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Paid, net of reinsurance, related to:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 6,466 ⟶ 6,528:
| style="text-align:right" | 253,481
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Net reserves for losses and LAE, end of period'''
| style="text-align:right" | '''1,397,729'''
| style="text-align:right" | '''1,111,537'''
| style="text-align:right" | '''859,017'''
|-
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period
Line 6,481 ⟶ 6,543:
| style="text-align:right" | 455,484
|-
| style="text-align:left" | '''Reserves for losses and LAE, end of period'''
| style="text-align:right" | '''2,318,894'''
| style="text-align:right" | '''1,782,383'''
| style="text-align:right" | '''1,314,501'''
|}
</div>
{{Indexing|Short Duration Contract Disclosures|Losses and LAE reserves
* ''Losses and LAE reserves'' represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates <sup>p. 96</sup>.
Line 6,498 ⟶ 6,560:
* Claim counts include all claims reported, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses) <sup>p. 96</sup>.
{{Indexing|Incurred losses and ALAE, net of reinsurance
<div style="overflow-x:auto">
Line 6,571 ⟶ 6,633:
| style="text-align:right" | 5,495
|-
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
Line 6,598 ⟶ 6,660:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | *Supplementary information and unaudited
Line 6,618 ⟶ 6,680:
</div>
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance
<div style="overflow-x:auto">
Line 6,674 ⟶ 6,736:
| style="text-align:right" | 79,856
|-
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | *Supplementary information and unaudited
Line 6,690 ⟶ 6,752:
</div>
{{Indexing|Incurred losses and ALAE, net of reinsurance by accident year
<div style="overflow-x:auto">
Line 6,865 ⟶ 6,927:
| style="text-align:right" | 6,139
|-
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
Line 6,907 ⟶ 6,969:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | *Supplementary information and unaudited
Line 6,937 ⟶ 6,999:
</div>
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance by accident year
<div style="overflow-x:auto">
Line 7,087 ⟶ 7,149:
| style="text-align:right" | 49,558
|-
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | *Supplementary information and unaudited
Line 7,113 ⟶ 7,175:
</div>
{{Indexing|Exited Lines — all lines in runoff|
* The provided table reconciles net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses as of December 31, 2025 and 2024 <sup>p. 97</sup>.
Line 7,119 ⟶ 7,181:
* This claims duration data is based on disaggregated information from paid loss development tables, net of reinsurance <sup>p. 97</sup>.
{{Indexing|Incurred losses and ALAE, net of reinsurance by accident year
<div style="overflow-x:auto">
Line 7,295 ⟶ 7,357:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
Line 7,337 ⟶ 7,399:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | *Supplementary information and unaudited
Line 7,367 ⟶ 7,429:
</div>
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance by accident year
<div style="overflow-x:auto">
Line 7,517 ⟶ 7,579:
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | *Supplementary information and unaudited
Line 7,543 ⟶ 7,605:
</div>
{{Indexing|Net reserves for losses and ALAE
<div style="overflow-x:auto">
Line 7,552 ⟶ 7,614:
|-
! style="text-align:left" | Net reserves for losses and ALAE:
! class="col-
! class="col-
|-
| style="text-align:left" | Short-tail/Monoline Specialty Lines
Line 7,567 ⟶ 7,629:
| style="text-align:right" | 86,689
|-
| style="text-align:left" | '''Reserves for losses and ALAE, net of reinsurance'''
| style="text-align:right" | '''1,367,038'''
| style="text-align:right" | '''1,084,980'''
|-
| style="text-align:left" | '''Reinsurance recoverable on unpaid claims:'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-tail/Monoline Specialty Lines
Line 7,583 ⟶ 7,649:
| style="text-align:right" | 15,298
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Unallocated LAE'''
| style="text-align:right" | '''30,691'''
| style="text-align:right" | '''26,557'''
|-
| style="text-align:left" | '''Reserves for losses and LAE at end of year'''
| style="text-align:right" | '''2,318,894'''
| style="text-align:right" | '''1,782,383'''
|}
</div>
{{Indexing|Average annual percentage payout of incurred claims by age
<div style="overflow-x:auto">
Line 7,654 ⟶ 7,720:
| style="text-align:right" | 1.3%
|-
| style="text-align:left" | '''*Supplementary information and unaudited'''
| style="text-align:right" | '''*Supplementary information and unaudited'''
| style="text-align:right" | '''*Supplementary information and unaudited'''
| style="text-align:right" | '''*Supplementary information and unaudited'''
| style="text-align:right" | '''*Supplementary information and unaudited'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 7,668 ⟶ 7,734:
</div>
{{Indexing|15. Commission and Fee Income|Skyward Underwriters Agency, Inc. (SUA),
* ''Skyward Underwriters Agency, Inc. (SUA)'' is a subsidiary of the Company <sup>p. 98</sup>.
Line 7,676 ⟶ 7,742:
* This income is derived from the placement of insurance policies with third-party insurance or reinsurance companies <sup>p. 98</sup>.
{{Indexing|Net commission and fee income
<div style="overflow-x:auto">
Line 7,700 ⟶ 7,766:
| style="text-align:right" | ( 135 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Commission and fee expenses
Line 7,710 ⟶ 7,776:
| style="text-align:right" | ( 3,755 )
|-
| style="text-align:left" | '''Net commission and fee income'''
| style="text-align:right" | '''6,855'''
| style="text-align:right" | '''6,703'''
| style="text-align:right" | '''6,064'''
|}
</div>
{{Indexing|Contract assets
<div style="overflow-x:auto">
Line 7,732 ⟶ 7,798:
</div>
{{Indexing|16. Underwriting, Acquisition and Insurance Expenses|Underwriting, acquisition and insurance expenses
* ''Underwriting, acquisition and insurance expenses'' were USD 390.0m in 2025, USD 330.0m in 2024, and USD 270.0m in 2023 <sup>p. 99</sup>.
Line 7,739 ⟶ 7,805:
* ''General and administrative expenses'' were USD 90.0m in 2025, USD 80.0m in 2024, and USD 70.0m in 2023 <sup>p. 99</sup>.
{{Indexing|
<div style="overflow-x:auto">
Line 7,758 ⟶ 7,824:
| style="text-align:right" | 134,930
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|17. Reinsurance|Reinsurance agreements
* ''Reinsurance agreements'' are used to assume and cede premiums and benefits with other insurance companies <sup>p. 100</sup>.
Line 7,782 ⟶ 7,848:
* The ''deposit asset'' was included in other assets on the Consolidated Balance Sheets <sup>p. 100</sup>.
{{Indexing|Premiums and ceded losses and LAE incurred
<div style="overflow-x:auto">
Line 7,792 ⟶ 7,858:
|-
! style="text-align:left" | ($ in thousands)
! class="col-
! class="col-
! class="col-
! class="col-
! class="col-s" style="text-align:right" | Written
! class="col-s" style="text-align:right" | Earned
Line 7,823 ⟶ 7,889:
| style="text-align:right" | ( 520,663 )
|-
| style="text-align:left" | '''Net premiums'''
| style="text-align:right" | '''1,406,232'''
| style="text-align:right" | '''1,304,505'''
| style="text-align:right" | '''1,123,578'''
| style="text-align:right" | '''1,056,722'''
| style="text-align:right" | '''910,691'''
| style="text-align:right" | '''829,143'''
|-
| style="text-align:left" | '''Ceded losses and LAE incurred'''
| style="text-align:right" | —
| style="text-align:right" | '''697,978'''
| style="text-align:right" | —
| style="text-align:right" | '''534,295'''
| style="text-align:right" | —
| style="text-align:right" | '''337,011'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | ($ in thousands)
! class="col-
! class="col-s" style="text-align:right" | 2024
|-
Line 7,865 ⟶ 7,931:
| style="text-align:right" | ( 2,295 )
|-
| style="text-align:left" | '''Reinsurance recoverables'''
| style="text-align:right" | '''1,119,880'''
| style="text-align:right" | '''857,876'''
|-
| style="text-align:left" | '''Ceded unearned premium'''
| style="text-align:right" | '''238,948'''
| style="text-align:right" | '''203,901'''
|}
</div>
{{Indexing|18. Stock Based Compensation|
* The ''2022 Long-Term Incentive Plan'' (2022 Plan) was approved by the Board of Directors on September 23, 2022, and became effective on January 12, 2023 <sup>p. 101</sup>.
Line 7,909 ⟶ 7,975:
* As of ''December 31, 2025'', the fair value of unrecognized ESPP expense was $0.3 million <sup>p. 101</sup>.
{{Indexing|ESPP awards by
<div style="overflow-x:auto">
Line 7,990 ⟶ 8,056:
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 8,006 ⟶ 8,072:
| style="text-align:right" | ( 219 )
|-
| style="text-align:left" | '''Outstanding at December 31, 2025'''
| style="text-align:right" | —
| style="text-align:right" | '''759,771'''
|}
</div>
{{Indexing|
<div style="overflow-x:auto">
Line 8,022 ⟶ 8,088:
| style="text-align:right" | 759,990
|-
| style="text-align:left" | '''Outstanding at December 31, 2024'''
| style="text-align:right" | '''759,990'''
|}
</div>
{{Indexing|Weighted-average grant-date fair value of stock and stock units
<div style="overflow-x:auto">
Line 8,033 ⟶ 8,099:
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Weighted-Average Grant-Date Fair Value
! class="col-
|-
| style="text-align:left" | Non-vested at January 1, 2025
Line 8,039 ⟶ 8,105:
| style="text-align:right" | 1,325,483
|-
| class="wt-indent-1" style="text-align:left" | Granted (1)
| style="text-align:right" | 47.77
| style="text-align:right" | 254,978
Line 8,047 ⟶ 8,113:
| style="text-align:right" | ( 391,746 )
|-
| class="wt-indent-1" style="text-align:left" | Forfeited (2)
| style="text-align:right" | 25.74
| style="text-align:right" | ( 53,247 )
|-
| style="text-align:left" | '''Non-vested at December 31, 2025'''
| style="text-align:right" | '''27.06'''
| style="text-align:right" | '''1,135,468'''
|-
| style="text-align:left" | Non-vested at January 1, 2024
Line 8,059 ⟶ 8,125:
| style="text-align:right" | 1,445,449
|-
| class="wt-indent-1" style="text-align:left" | Granted (1)
| style="text-align:right" | 31.72
| style="text-align:right" | 268,631
Line 8,067 ⟶ 8,133:
| style="text-align:right" | ( 285,957 )
|-
| class="wt-indent-1" style="text-align:left" | Forfeited (2)
| style="text-align:right" | 18.27
| style="text-align:right" | ( 102,640 )
|-
| style="text-align:left" | '''Non-vested at December 31, 2024'''
| style="text-align:right" | '''19.06'''
| style="text-align:right" | '''1,325,483'''
|-
| style="text-align:left" | Non-vested at January 1, 2023
Line 8,079 ⟶ 8,145:
| style="text-align:right" | 419,896
|-
| class="wt-indent-1" style="text-align:left" | Granted (1)
| style="text-align:right" | 16.07
| style="text-align:right" | 1,101,856
Line 8,087 ⟶ 8,153:
| style="text-align:right" | ( 40,645 )
|-
| class="wt-indent-1" style="text-align:left" | Forfeited (2)
| style="text-align:right" | 15.29
| style="text-align:right" | ( 35,658 )
|-
| style="text-align:left" | '''Non-vested at December 31, 2023'''
| style="text-align:right" | '''15.13'''
| style="text-align:right" | '''1,445,449'''
|}
</div>
Line 8,100 ⟶ 8,166:
(2) Decreases below the 100% target level are reflected as forfeited.
{{Indexing|19. Earnings Per Share|
* The table sets forth the computation of ''basic and diluted net earnings per share'' for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>.
Line 8,106 ⟶ 8,172:
* The table presents ''common share equivalents of contingently issuable instruments'' excluded from basic earnings per share for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>.
{{Indexing|Anti-dilutive instruments excluded from diluted weighted-average common share equivalents
<div style="overflow-x:auto">
Line 8,116 ⟶ 8,182:
|-
! style="text-align:left" | Numerator
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Net income
Line 8,125 ⟶ 8,191:
| style="text-align:right" | 85,984
|-
| style="text-align:left" | '''Less: Undistributed income allocated to participating securities'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''( 1,677 )'''
|-
| style="text-align:left" | Net income attributable to common stockholders (numerator for basic earnings per share)
Line 8,140 ⟶ 8,206:
| style="text-align:right" | 1,677
|-
| style="text-align:left" | '''Net income (numerator for diluted earnings per share under the two-class method)'''
| style="text-align:right" | '''170,028'''
| style="text-align:right" | '''118,828'''
| style="text-align:right" | '''85,984'''
|-
| style="text-align:left" | Basic weighted-average common shares
Line 8,170 ⟶ 8,236:
| style="text-align:right" | 135,972
|-
| style="text-align:left" | '''Diluted weighted-average common share equivalents'''
| style="text-align:right" | '''41,808,046'''
| style="text-align:right" | '''41,377,460'''
| style="text-align:right" | '''38,317,534'''
|-
| style="text-align:left" | '''Basic earnings per share'''
| style="text-align:right" | '''4.21'''
| style="text-align:right" | '''2.97'''
| style="text-align:right" | '''2.34'''
|-
| style="text-align:left" | Diluted earnings per share
Line 8,187 ⟶ 8,253:
</div>
{{Indexing|Stock units and options for 2023
<div style="overflow-x:auto">
Line 8,208 ⟶ 8,274:
</div>
{{Indexing|Common shares for 2023
<div style="overflow-x:auto">
Line 8,222 ⟶ 8,288:
| style="text-align:right" | 920,864
|-
| class="wt-indent-1" style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|20. Employee Benefit Plan|
* The Company sponsors the ''401(k) Plan'' (the “Plan”), which is available to substantially all its employees <sup>p. 103</sup>.
Line 8,239 ⟶ 8,305:
** ''2023'': USD 2.9m <sup>p. 103</sup>
{{Indexing|Riscom|RISCOM
* ''RISCOM'' provides wholesale brokerage services to the Company <sup>p. 104</sup>.
Line 8,247 ⟶ 8,313:
* ''Premiums receivable'' as of December 31, 2024, were USD 12.6m <sup>p. 104</sup>.
{{Indexing|Premiums receivable
<div style="overflow-x:auto">
Line 8,268 ⟶ 8,334:
</div>
{{Indexing|Other|Advisory and professional services fees
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024 <sup>p. 105</sup>.
Line 8,274 ⟶ 8,340:
* For investments involving affiliated companies and additional related party transactions, refer to Notes 5, 6, and 11 <sup>p. 105</sup>.
{{Indexing|Litigation|
* The Company is involved in various legal actions stemming from claims under insurance policies and contracts <sup>p. 106</sup>.
Line 8,282 ⟶ 8,348:
* Based on current information, available insurance coverage, and advice from legal counsel, the Company believes the resolution of these matters will not individually or in aggregate have a material adverse effect on its consolidated financial position, results of operations, or cash flows <sup>p. 106</sup>.
{{Indexing|Indemnification|
* The Company has provided ''indemnifications'' to certain buyers in conjunction with the sale of business assets and subsidiaries <sup>p. 107</sup>.
Line 8,290 ⟶ 8,356:
* The Company currently ''does not believe'' any significant claims exist related to these indemnifications <sup>p. 107</sup>.
{{Indexing|23. Statutory Accounting Principles and Regulatory Matters|Statutory
* ''Statutory net income'' was $159.1 million for 2025, $108.2 million for 2024, and $73.1 million for 2023 <sup>p. 108</sup>.
Line 8,307 ⟶ 8,373:
* As of December 31, 2025, and 2024, GMIC’s statutory capital and surplus substantially exceeded the regulatory RBC requirements <sup>p. 108</sup>.
{{Indexing|24. Subsequent Events|
* On September 2, 2025, the Company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") <sup>p. 109</sup>.
Line 8,320 ⟶ 8,386:
== Controls and Procedures ==
{{Indexing|Evaluation of Disclosure Controls and Procedures|
* Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K <sup>p. 110</sup>.
Line 8,327 ⟶ 8,393:
* Management acknowledges that any controls and procedures can only provide reasonable assurance of achieving their objectives, and judgment is applied in evaluating the cost-benefit relationship of controls and procedures <sup>p. 110</sup>.
{{Indexing|Management’s Report on Internal Control over Financial Reporting|
* ''Management'' is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended <sup>p. 111</sup>.
Line 8,335 ⟶ 8,401:
* ''Internal control over financial reporting'' includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements <sup>p. 111</sup>.
{{Indexing|Remediation of Material Weakness in Internal Control Over Financial Reporting|
* ''Material weakness'' in internal control over financial reporting was identified as of December 31, 2024, related to ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes <sup>p. 112</sup>.
* Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective <sup>p. 112</sup>.
* During the year ended December 31, 2025, management took actions to remediate
* Remediation actions included enhancing the IT compliance oversight function and expanding the team with ITGC design and implementation experience <sup>p. 112</sup>.
* A training program addressing ITGCs and policies was developed, educating control owners on principles and requirements <sup>p. 112</sup>.
Line 8,345 ⟶ 8,411:
* An IT management review and testing procedures were implemented to monitor ITGCs <sup>p. 112</sup>.
* Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors <sup>p. 112</sup>.
* Management believes the measures remediated the material weakness and concluded that ''internal control over financial reporting'' was effective
* The assessment of effectiveness of internal control over financial reporting
* The assessment used criteria set forth by the Committee of Sponsoring Organizations of the
* Based on this assessment, management concluded that ''internal control over financial reporting'' was effective as of December 31, 2025 <sup>p. 112</sup>.
* The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm <sup>p. 112</sup>.
* Ernst & Young, LLP's report is titled “Report of Independent Registered Public Accounting Firm-Opinion on Internal Control over Financial Reporting” <sup>p. 112</sup>.
{{Indexing|Changes in Internal Control over Financial Reporting|
* No change in internal control over financial reporting was identified during the year ended December 31, 2025, in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act, except for the remediation of the material weakness identified in 2024 <sup>p. 113</sup>.
* These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting <sup>p. 113</sup>.
{{Indexing|Limitations on Effectiveness of Controls and Procedures|
* Management acknowledges that disclosure controls and procedures, regardless of their design and operation, offer only reasonable assurance of achieving control objectives <sup>p. 114</sup>.
Line 8,366 ⟶ 8,435:
== Directors, Executive Officers and Corporate Governance ==
* The information required by Item 10 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference <sup>p. 116</sup>.
== Executive Compensation ==
Line 8,382 ⟶ 8,451:
== Principal Accounting Fees and Services ==
*
* The
*
== Exhibits, Financial Statement Schedules. ==
Line 8,398 ⟶ 8,467:
* Items marked with a plus (+) indicate a management contract or compensatory plan or arrangement <sup>p. 121</sup>.
{{Indexing|
<div style="overflow-x:auto">
Line 8,428 ⟶ 8,497:
</div>
{{Indexing|Exhibit numbers and descriptions
<div style="overflow-x:auto">
Line 8,467 ⟶ 8,536:
</div>
{{Indexing|Exhibit numbers and descriptions
<div style="overflow-x:auto">
Line 8,533 ⟶ 8,602:
</div>
{{Indexing|Exhibit numbers and descriptions
<div style="overflow-x:auto">
Line 8,593 ⟶ 8,662:
</div>
{{Indexing|Exhibit numbers and descriptions
<div style="overflow-x:auto">
Line 8,638 ⟶ 8,707:
</div>
{{Indexing|Fixed maturity securities
<div style="overflow-x:auto">
Line 8,687 ⟶ 8,756:
| style="text-align:right" | 513,695
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Other asset-backed securities
Line 8,697 ⟶ 8,766:
| style="text-align:right" | 32,822
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Preferred stocks
Line 8,707 ⟶ 8,776:
| style="text-align:right" | 1,174
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Mortgage loans'''
| style="text-align:right" | '''10,093'''
| style="text-align:right" | '''9,902'''
| style="text-align:right" | '''9,902'''
|-
| style="text-align:left" | '''Other long-term investments'''
| style="text-align:right" | '''37,290'''
| style="text-align:right" | '''58,650'''
| style="text-align:right" | '''58,650'''
|-
| style="text-align:left" | '''Short-term investments'''
| style="text-align:right" | '''264,299'''
| style="text-align:right" | '''264,299'''
| style="text-align:right" | '''264,299'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|Assets as of December 31
<div style="overflow-x:auto">
Line 8,750 ⟶ 8,819:
|-
! style="text-align:left" | Investments:
! class="col-
! class="col-s" style="text-align:right" | —
|-
Line 8,761 ⟶ 8,830:
| style="text-align:right" | 14,000
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Cash and cash equivalents
Line 8,781 ⟶ 8,850:
| style="text-align:right" | 2,905
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Liabilities and Stockholders’ Equity'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 8,801 ⟶ 8,870:
| style="text-align:right" | 19,536
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Stockholders’ Equity:'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Stockholders’ equity'''
| style="text-align:right" | '''1,009,565'''
| style="text-align:right" | '''793,999'''
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
{{Indexing|(parent company)|Parent company financial statements
* See accompanying notes to financial statements <sup>p. 122</sup>.
{{Indexing|Revenues and expenses for years ended December 31
<div style="overflow-x:auto">
Line 8,855 ⟶ 8,924:
| style="text-align:right" | ( 27 )
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Operating expenses
Line 8,880 ⟶ 8,949:
| style="text-align:right" | 451
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | '''Loss before income tax expense'''
| style="text-align:right" | '''( 29,872 )'''
| style="text-align:right" | '''( 25,165 )'''
| style="text-align:right" | '''( 7,747 )'''
|-
| style="text-align:left" | Income tax expense
Line 8,895 ⟶ 8,964:
| style="text-align:right" | 6,808
|-
| style="text-align:left" | '''Loss before equity in earnings of subsidiaries'''
| style="text-align:right" | '''( 75,732 )'''
| style="text-align:right" | '''( 58,743 )'''
| style="text-align:right" | '''( 14,555 )'''
|-
| style="text-align:left" | '''Equity in undistributed earnings of subsidiaries'''
| style="text-align:right" | '''245,760'''
| style="text-align:right" | '''177,571'''
| style="text-align:right" | '''100,539'''
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | '''170,028'''
| style="text-align:right" | '''118,828'''
| style="text-align:right" | '''85,984'''
|}
</div>
{{Indexing|Schedule ii — statements of cash flows (parent company)|
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>.
Line 8,933 ⟶ 9,002:
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>.
{{Indexing|Cash flows
<div style="overflow-x:auto">
Line 8,948 ⟶ 9,017:
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
! class="col-
|-
| style="text-align:left" | Net income
Line 8,960 ⟶ 9,029:
| style="text-align:right" | ( 95,947 )
|-
| style="text-align:left" | '''Net cash used in operating activities'''
| style="text-align:right" | '''( 5,741 )'''
| style="text-align:right" | '''( 2,735 )'''
| style="text-align:right" | '''( 9,963 )'''
|-
| style="text-align:left" | Purchase of intangible assets and goodwill
Line 8,985 ⟶ 9,054:
| style="text-align:right" | ( 10,569 )
|-
| style="text-align:left" | '''Net cash provided by (used in) investing activities'''
| style="text-align:right" | '''5,887'''
| style="text-align:right" | '''5,093'''
| style="text-align:right" | '''( 126,869 )'''
|-
| style="text-align:left" | Repayment of stock notes receivable
Line 9,015 ⟶ 9,084:
| style="text-align:right" | 710
|-
| style="text-align:left" | '''Net cash provided by (used in) financing activities'''
| style="text-align:right" | '''411'''
| style="text-align:right" | '''( 2,439 )'''
| style="text-align:right" | '''130,947'''
|-
| style="text-align:left" | '''Net increase (decrease) in cash and cash equivalents and restricted cash'''
| style="text-align:right" | '''557'''
| style="text-align:right" | '''( 81 )'''
| style="text-align:right" | '''( 5,885 )'''
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year
Line 9,030 ⟶ 9,099:
| style="text-align:right" | 8,909
|-
| style="text-align:left" | '''Cash and cash equivalents and restricted cash at end of year'''
| style="text-align:right" | '''3,500'''
| style="text-align:right" | '''2,943'''
| style="text-align:right" | '''3,024'''
|-
| style="text-align:left" | '''Supplemental disclosure of cash flow information:'''
| style="text-align:right" | —
| style="text-align:right" | —
Line 9,047 ⟶ 9,116:
</div>
{{Indexing|Notes to Financial Statements|
* ''Intercompany Loan Promissory Note'' was entered into by Skyward Specialty with Houston Specialty Insurance Company (HSIC) on September 30, 2024 <sup>p. 124</sup>.
Line 9,058 ⟶ 9,127:
* ''Skyward Specialty No. 1 Limited Company'' is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates <sup>p. 124</sup>.
{{Indexing|Financial Instruments Disclosed, But Not Carried, At Fair Value|
* The ''Promissory Note'' between Skyward Specialty and HSIC is included in notes payable <sup>p. 125</sup>.
Line 9,065 ⟶ 9,134:
* ''Other financial instruments'' are exempt from fair value disclosure requirements as they qualify as insurance-related products <sup>p. 125</sup>.
{{Indexing|Notes payable and promissory note
<div style="overflow-x:auto">
Line 9,093 ⟶ 9,162:
</div>
{{Indexing|Gross, ceded, assumed, and net amounts|Gross
<div style="overflow-x:auto">
Line 9,107 ⟶ 9,176:
! style="text-align:left" | ($ in thousands)
! class="col-s" style="text-align:right" | Accident & Health
! class="col-
! class="col-s" style="text-align:right" | Accident & Health
! class="col-
! class="col-s" style="text-align:right" | Accident & Health
! class="col-s" style="text-align:right" | Property & Casualty
Line 9,137 ⟶ 9,206:
| style="text-align:right" | 218,649
|-
| style="text-align:left" | '''Net amount'''
| style="text-align:right" | '''110,291'''
| style="text-align:right" | '''1,295,941'''
| style="text-align:right" | '''86,570'''
| style="text-align:right" | '''1,037,008'''
| style="text-align:right" | '''72,611'''
| style="text-align:right" | '''838,080'''
|-
| style="text-align:left" | '''Percentage of amount assumed to net'''
| style="text-align:right" | '''—%'''
| style="text-align:right" | '''37.2%'''
| style="text-align:right" | '''—%'''
| style="text-align:right" | '''27.4%'''
| style="text-align:right" | '''—%'''
| style="text-align:right" | '''26.1%'''
|}
</div>
{{Indexing|Valuation
<div style="overflow-x:auto">
Line 9,174 ⟶ 9,243:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Charged to costs and expenses'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''748'''
|-
| style="text-align:left" | Amounts written off
Line 9,189 ⟶ 9,258:
| style="text-align:right" | 100
|-
| style="text-align:left" | '''Balance at December 31, 2023'''
| style="text-align:right" | '''586'''
| style="text-align:right" | '''2,295'''
| style="text-align:right" | '''964'''
|-
| style="text-align:left" | '''Charged to costs and expenses'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''13,585'''
| style="text-align:right" | '''3,235'''
|-
| style="text-align:left" | Amounts written off
Line 9,209 ⟶ 9,278:
| style="text-align:right" | 128
|-
| style="text-align:left" | '''Balance at December 31, 2024'''
| style="text-align:right" | '''586'''
| style="text-align:right" | '''2,295'''
| style="text-align:right" | '''2,432'''
|-
| style="text-align:left" | '''Charged to costs and expenses'''
| style="text-align:right" | '''68'''
| style="text-align:right" | '''—'''
| style="text-align:right" | '''2,351'''
|-
| style="text-align:left" | Amounts written off
Line 9,229 ⟶ 9,298:
| style="text-align:right" | 498
|-
| style="text-align:left" | '''Balance at December 31, 2025'''
| style="text-align:right" | '''654'''
| style="text-align:right" | '''2,295'''
| style="text-align:right" | '''3,140'''
|}
</div>
{{Indexing|Deferred policy acquisition costs and
<div style="overflow-x:auto">
Line 9,313 ⟶ 9,382:
(2) Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations.
{{Indexing|Signatures|
* This report was signed on behalf of the registrant pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 <sup>p. 126</sup>.
* This report was signed by the indicated persons on behalf of the Registrant, in their capacities, and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934 <sup>p. 126</sup>.
{{Indexing|
<div style="overflow-x:auto">
Line 9,333 ⟶ 9,402:
</div>
{{Indexing|Signatures, titles, and dates
<div style="overflow-x:auto">
Line 9,345 ⟶ 9,414:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Andrew Robinson'''
| style="text-align:left" | '''(Principal Executive Officer)'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Mark Haushill
Line 9,353 ⟶ 9,422:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Mark Haushill'''
| style="text-align:left" | '''(Principal Financial and Accounting Officer)'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Gena Ashe
Line 9,361 ⟶ 9,430:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Gena Ashe'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Robert Creager
Line 9,369 ⟶ 9,438:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Robert Creager'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Marcia Dall
Line 9,377 ⟶ 9,446:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Marcia Dall'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ James Hays
Line 9,385 ⟶ 9,454:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''James Hays'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Anthony J. Kuczinski
Line 9,393 ⟶ 9,462:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Anthony J. Kuczinski'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Michael Morrissey
Line 9,401 ⟶ 9,470:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Michael Morrissey'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Christopher L. Peirce
Line 9,409 ⟶ 9,478:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Christopher L. Peirce'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|-
| style="text-align:left" | /s/ Katharine Terry
Line 9,417 ⟶ 9,486:
| class="col-s" style="text-align:right" | March 2, 2026
|-
| style="text-align:left" | '''Katharine Terry'''
| style="text-align:left" | '''Director'''
| class="col-s" style="text-align:right" | '''March 2, 2026'''
|}
</div>
| |||